Selected Publications

  1. Ahmed S, Plazier M, Ost J, Stassijns G, Deleye S, Ceyssens S, Dupont P, Stroobants S, Staelens S, De Ridder D: The effect of occipital nerve field stimulation on the descending pain pathway in patients with fibromyalgia: a water PET and EEG imaging study. BMC neurology 2018, 18(1):191.
  2. Akamatsu G, Tashima H, Iwao Y, Wakizaka H, Maeda T, Yoshida E, Yamaya T: A 3-dimensional hemispherical brain phantom for compact dedicated brain PET scanners. Biomedical Physics & Engineering Express 2018.
  3. Akkus F, Mihov Y, Treyer V, Ametamey SM, Johayem A, Senn S, Rösner S, Buck A, Hasler G: Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder. Translational psychiatry 2018, 8(1):17.
  4. Albatly AA, Alsamarah AT, Alhawas A, Veit-Haibach P, Buck A, Stolzmann P, Burger IA, Kollias SS, Huellner MW: Value of 18F-FET PET in adult brainstem glioma. Clinical imaging 2018, 51:68-75.
  5. Alecxih A, Sorci O, Batzdorf A, Churilla J, Peng M, Jankelovits A, Rhodes S, Kim J, Johncola A, Hornyak J: Sodium Fluoride PET/CT Imaging as a Promising Tool for the Assessment of Coronary Plaque Deposition. Journal of Nuclear Medicine 2018, 59(supplement 1):298-298.
  6. Allen KJ, Jiao R, Malo ME, Dadachova E: Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with 188Rhenium. Cancer biotherapy & radiopharmaceuticals 2018, 33(8):349-355.
  7. Alves CR, das Neves W, Tobias GC, Almeida NR, Barreto RF, Melo CM, Carneiro CG, Garcez AT, Faria DP, Chammas R: High-intensity interval training slows down tumor progression in mice bearing Lewis lung carcinoma. JCSM Rapid Communications 2018, 1(2).
  8. Alves CR, Faria DdP, Carneiro CdG, Garcez AT, Gutierrez VP, das Neves W, de Almeida NR, Cury Y, Chammas R, Brum PC: 18F-Fluoride PET/CT and 99mTc-MDP SPECT/CT can detect bone cancer at early stage in rodents. Life sciences 2018, 206:29-34.
  9. Alves IL, García DVV, Parente A, Doorduin J, da Silva AMM, Koole M, Dierckx R, Willemsen A, Boellaard R: Parametric Imaging of [11 C] Flumazenil Binding in the Rat Brain. Molecular Imaging and Biology 2018, 20(1):114-123.
  10. Amato E, Cicone F, Auditore L, Baldari S, Prior JO, Gnesin S: A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures. Physica Medica 2018, 49:52-57.
  11. Amor D, Goutal S, Marie S, Caillé F, Bauer M, Langer O, Auvity S, Tournier N: Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats. EJNMMI research 2018, 8(1):81.
  12. Anwar H, Sachpekidis C, Winkler J, Kopp-Schneider A, Haberkorn U, Hassel JC, Dimitrakopoulou-Strauss A: Absolute number of new lesions on 18 F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. European journal of nuclear medicine and molecular imaging 2018, 45(3):376-383.
  13. Aoe J, Watabe T, Shimosegawa E, Kato H, Kanai Y, Naka S, Matsunaga K, Isohashi K, Tatsumi M, Hatazawa J: Evaluation of the default-mode network by quantitative 15 O-PET: comparative study between cerebral blood flow and oxygen consumption. Annals of Nuclear Medicine 2018:1-7.
  14. Arakawa R, Farde L, Matsumoto J, Kanegawa N, Yakushev I, Yang K-C, Takano A: Potential Effect of Prolonged Sevoflurane Anesthesia on the Kinetics of [11 C] Raclopride in Non-human Primates. Molecular Imaging and Biology 2018, 20(2):183-187.
  15. Asai K, Nakamura H, Watabe T, Nishida T, Sakaguchi M, Hatazawa J, Yoshimine T, Kishima H: X-ray angiography perfusion imaging with an intra-arterial injection: comparative study with 15O-gas/water positron emission tomography. Journal of neurointerventional surgery 2018, 10(8):780-783.
  16. Auvity S, Caillé F, Marie S, Wimberley C, Bauer M, Langer O, Buvat I, Goutal S, Tournier N: P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of 11C-Metoclopramide Across the Blood–Brain Barrier: A PET Study on Nonhuman Primates. Journal of Nuclear Medicine 2018, 59(10):1609-1615.
  17. Avendaño‐Estrada A, Ávila‐Rodríguez MA: Reference tissue models in the assessment of 11C‐DTBZ binding to the VMAT2 in rat striatum: A test‐retest reproducibility study. Synapse 2018, 72(6):e22029.
  18. Bahri S, Horowitz M, Malbert CH: Inward Glucose Transfer Accounts for Insulin‐Dependent Increase in Brain Glucose Metabolism Associated with Diet‐Induced Obesity. Obesity 2018.
  19. Baker LC, Sikka A, Price JM, Boult JK, Lepicard EY, Box G, Jamin Y, Spinks TJ, Kramer-Marek G, Leach MO: Evaluating imaging biomarkers of acquired resistance to targeted EGFR therapy in xenograft models of human head and neck squamous cell carcinoma. Frontiers in oncology 2018, 8:271.
  20. Bankstahl M, Breuer H, Leiter I, Märkel M, Bascuñana P, Michalski D, Bengel FM, Löscher W, Meier M, Bankstahl JP: Blood-Brain Barrier Leakage during Early Epileptogenesis Is Associated with Rapid Remodeling of the Neurovascular Unit. eNeuro 2018:ENEURO. 0123-0118.2018.
  21. Barbagallo M, Albatly AA, Schreiner S, Hayward-Könnecke HK, Buck A, Kollias SS, Huellner MW: Value of 18F-FET PET in Patients With Suspected Tumefactive Demyelinating Disease—Preliminary Experience From a Retrospective Analysis. Clinical nuclear medicine 2018, 43(11):e385-e391.
  22. Barry RL, Byun NE, Williams JM, Siuta MA, Tantawy MN, Speed NK, Saunders C, Galli A, Niswender KD, Avison MJ: Brief exposure to obesogenic diet disrupts brain dopamine networks. PloS one 2018, 13(4):e0191299.
  23. Bascuñana P, Brackhan M, Leiter I, Keller H, Jahreis I, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: Divergent metabolic substrate utilization in brain during epileptogenesis precedes chronic hypometabolism. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18809886.
  24. Bauer M, Matsuda A, Wulkersdorfer B, Philippe C, Traxl A, Özvegy‐Laczka C, Stanek J, Nics L, Klebermass EM, Poschner S: Influence of OATPs on hepatic disposition of erlotinib measured with positron emission tomography. Clinical Pharmacology & Therapeutics 2018, 104(1):139-147.
  25. Bauer M, Traxl A, Matsuda A, Karch R, Philippe C, Nics L, Klebermass E-M, Wulkersdorfer B, Weber M, Poschner S: Effect of Rifampicin on the Distribution of [11C] Erlotinib to the Liver, a Translational PET Study in Humans and in Mice. Molecular pharmaceutics 2018, 15(10):4589-4598.
  26. Baumgartner A, Frings L, Schiller F, Stich O, Mix M, Egger K, Schluh G, Rauer S, Meyer PT: Regional neuronal activity in patients with relapsing remitting multiple sclerosis. Acta Neurologica Scandinavica 2018, 138(6):466-474.
  27. Beaufils E, Vercouillie J, Vierron E, Cottier J-P, Camus V, Mondon K, Guilloteau D, Hommet C, Ribeiro MJ: Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes. Clinical nuclear medicine 2018, 43(4):e103-e108.
  28. Becker AS, Boss A, Klarhoefer M, Finkenstaedt T, Wurnig MC, Rossi C: Investigation of the pulsatility of cerebrospinal fluid using cardiac-gated Intravoxel Incoherent Motion imaging. Neuroimage 2018, 169:126-133.
  29. Beckers L, Ory D, Geric I, Declercq L, Koole M, Kassiou M, Bormans G, Baes M: Increased expression of translocator protein (TSPO) marks pro-inflammatory microglia but does not predict neurodegeneration. Molecular imaging and biology 2018, 20(1):94-102.
  30. Bejanin A, La Joie R, Landeau B, Belliard S, de La Sayette V, Eustache F, Desgranges B, Chételat G: Distinct Interplay Between Atrophy and Hypometabolism in Alzheimer’s Versus Semantic Dementia. Cerebral Cortex 2018.
  31. Belloli S, Zanotti L, Murtaj V, Mazzon C, Di Grigoli G, Monterisi C, Masiello V, Iaccarino L, Cappelli A, Poliani PL: 18 F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis. Journal of neuroinflammation 2018, 15(1):33.
  32. Bertelsen F, Landau AM, Vase KH, Jacobsen J, Scheel-Krüger J, Møller A: Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [11C] Ro15-4513 microPET study. Brain research 2018, 1680:110-114.
  33. Bertoglio D, Kosten L, Verhaeghe J, Thomae D, Wyffels L, Stroobants S, Wityak J, Dominguez C, Mrzljak L, Staelens S: Longitudinal Characterization of mGluR5 Using 11C-ABP688 PET Imaging in the Q175 Mouse Model of Huntington Disease. Journal of Nuclear Medicine 2018, 59(11):1722-1727.
  34. Bertoglio D, Verhaeghe J, Kosten L, Thomae D, Van der Linden A, Stroobants S, Wityak J, Dominguez C, Mrzljak L, Staelens S: MR-based spatial normalization improves [18F] MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington’s disease. PloS one 2018, 13(10):e0206613.
  35. Beshr R, Isohashi K, Watabe T, Naka S, Horitsugi G, Romanov V, Kato H, Miyatake S-I, Shimosegawa E, Hatazawa J: Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [18 F] fluoro-borono-phenylalanine PET/CT. Annals of nuclear medicine 2018, 32(10):702-708.
  36. Bhagat PN, Jadhav SH, Chattopadhyay S, Paknikar KM: Carbon nanospheres mediated nuclear delivery of SMAR1 protein (DNA binding domain) controls breast tumor in mice model. Nanomedicine 2018, 13(4):353-372.
  37. Blakkisrud J, Holtedahl JE, Løndalen A, Dahle J, Bach-Gansmo T, Holte H, Nygaard S, Kolstad A, Stokke C: Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody–Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2018, 59(4):704-710.
  38. Blautzik J, Kotz S, Brendel M, Sauerbeck J, Vettermann F, Winter Y, Bartenstein P, Ishii K, Rominger A, Initiative AsDN: Relationship between body mass index, ApoE4 status, and PET-based amyloid and neurodegeneration markers in amyloid-positive subjects with normal cognition or mild cognitive impairment. Journal of Alzheimer’s Disease 2018, 65(3):781-791.
  39. Blume T, Focke C, Peters F, Deussing M, Albert NL, Lindner S, Gildehaus F-J, von Ungern-Sternberg B, Ozmen L, Baumann K: Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study. Journal of neuroinflammation 2018, 15(1):307.
  40. Bodart G, Farhat K, Renard-Charlet C, Becker G, Plenevaux A, Salvatori R, Geenen V, Martens H: The Severe Deficiency of the Somatotrope GH-Releasing Hormone/Growth Hormone/Insulin-Like Growth Factor 1 Axis of Ghrh−/− Mice Is Associated With an Important Splenic Atrophy and Relative B Lymphopenia. Frontiers in endocrinology 2018, 9.
  41. Bodart G, Farhat K, Renard-Charlet C, Becker G, Plenevaux A, Salvatori R, Geenen V, Martens H: The severe deficiency of the somatotrope GHRH/GH/IGF-1 axis of Ghrh-/-mice is associated with an important splenic atrophy and relative B lymphopenia. Frontiers in Endocrinology 2018, 9:296.
  42. Bonaventura J, Eldridge MA, Hu F, Gomez JL, Sanchez-Soto M, Abramyan AM, Lam S, Boehm M, Ruiz C, Farrell M: Chemogenetic ligands for translational neurotheranostics. bioRxiv 2018:487637.
  43. Brackhan M, Bascuñana P, Ross TL, Bengel FM, Bankstahl JP, Bankstahl M: [18F] GE 180 positron emission tomographic imaging indicates a potential double‐hit insult in the intrahippocampal kainate mouse model of temporal lobe epilepsy. Epilepsia 2018, 59(3):617-626.
  44. Breining P, Jensen JB, Sundelin EI, Gormsen LC, Jakobsen S, Busk M, Rolighed L, Bross P, Fernandez‐Guerra P, Markussen LK: Metformin Targets Brown Adipose Tissue in vivo and Reduces Oxygen Consumption in vitro. Diabetes, Obesity and Metabolism 2018.
  45. Brendel M, Sauerbeck J, Greven S, Kotz S, Scheiwein F, Blautzik J, Delker A, Pogarell O, Ishii K, Bartenstein P: Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer’s Disease Patients with Depressive Symptoms. Journal of Alzheimer’s Disease 2018(Preprint):1-14.
  46. Brendel M, Schönecker S, Höglinger G, Lindner S, Havla J, Blautzik J, Sauerbeck J, Rohrer G, Zach C, Vettermann F: [18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy. Frontiers in aging neuroscience 2018, 9:440.
  47. Brendel M, Yousefi BH, Blume T, Herz M, Focke C, Deussing M, Peters F, Lindner S, von Ungern-Sternberg B, Drzezga A: Comparison of 18F-T807 and 18F-THK5117 PET in a mouse model of tau pathology. Frontiers in aging neuroscience 2018, 10.
  48. Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, Kotta KK, London ED, Okita K, Nurmi EL: Effect of overnight smoking abstinence on a marker for microglial activation: a [11 C] DAA1106 positron emission tomography study. Psychopharmacology 2018, 235(12):3525-3534.
  49. Brunton B, Suksanpaisan L, Li H, Liu Q, Yu Y, Vrieze A, Zhang L, Jenks N, Jiang H, DeGrado TR: New transgenic NIS reporter rats for longitudinal tracking of fibrogenesis by high-resolution imaging. Scientific reports 2018, 8(1):14209.
  50. Bunai T, Terada T, Kono S, Yokokura M, Yoshikawa E, Futatsubashi M, Miyajima H, Ouchi Y: Neuroinflammation following disease modifying therapy in multiple sclerosis: A pilot positron emission tomography study. Journal of the neurological sciences 2018, 385:30-33.
  51. Burger IA, Lohmann C, Messerli M, Bengs S, Becker A, Maredziak M, Treyer V, Haider A, Schwyzer M, Benz DC: Age-and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imaging. PloS one 2018, 13(8):e0202302.
  52. Burley TA, Da Pieve C, Martins CD, Ciobota DM, Allott L, Oyen WJ, Harrington KJ, Smith G, Kramer-Marek G: Affibody-based PET imaging to guide EGFR-targeted cancer therapy in head and neck squamous cell cancer models. Journal of Nuclear Medicine 2018:jnumed. 118.216069.
  53. Caillé F, Goutal S, Marie S, Auvity S, Cisternino S, Kuhnast B, Pottier G, Tournier N: Positron Emission Tomography Imaging Reveals an Importance of Saturable Liver Uptake Transport for the Pharmacokinetics of Metoclopramide. Contrast media & molecular imaging 2018, 2018.
  54. Caravaggio F, Fervaha G, Browne CJ, Gerretsen P, Remington G, Graff-Guerrero A: Reward motivation in humans and its relationship to dopamine D2/3 receptor availability: A pilot study with dual [11C]-raclopride and [11C]-(+)-PHNO imaging. Journal of Psychopharmacology 2018, 32(3):357-366.
  55. Caravaggio F, Scifo E, Sibille EL, Hernandez-Da Mota SE, Gerretsen P, Remington G, Graff-Guerrero A: Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry. Experimental eye research 2018.
  56. Catarina AV, Luft C, Greggio S, Venturin GT, Ferreira F, Marques EP, Rodrigues L, Wartchow K, Leite MC, Gonçalves CA: Fructose-1, 6-bisphosphate preserves glucose metabolism integrity and reduces reactive oxygen species in the brain during experimental sepsis. Brain Research 2018.
  57. Ceccon G, Lazaridis L, Stoffels G, Rapp M, Weber M, Blau T, Lohmann P, Kebir S, Herrmann K, Fink GR: Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience. European journal of nuclear medicine and molecular imaging 2018:1-10.
  58. Chang C-W, Yeh C-N, Chung Y-H, Chen Y-R, Tien S-W, Chen T-W, Farn S-S, Huang Y-C, Yu C-S: synthesis and evaluation of ortho-[18F] fluorocelecoxib for COX-2 cholangiocarcinoma imaging. Drug design, development and therapy 2018, 12:1467.
  59. Chang PMH, Cheng CT, Wu RC, Chung YH, Chiang KC, Yeh TS, Liu CY, Chen MH, Chen MH, Yeh CN: Nab‑paclitaxel is effective against intrahepatic cholangiocarcinoma via disruption of desmoplastic stroma. Oncology Letters 2018, 16(1):566-572.
  60. Chantepie S, Hovhannisyan N, Guillouet S, Pelage J-P, Ibazizene M, Bodet-Milin C, Carlier T, Gac A-C, Réboursière E, Vilque J-P: 18F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients. Journal of Nuclear Medicine 2018, 59(9):1380-1385.
  61. Chen B, Zhang W, Ji B, Ma Q, Li D, Gao S: Integrin αVβ3‑targeted SPECT/CT for the assessment of Bevacizumab therapy in orthotopic lung cancer xenografts. Oncology letters 2018, 15(4):4201-4206.
  62. Chen J, Pang W, Kan Y, Zhao L, He Z, Shi W, Yan B, Chen H, Hu J: Structure of a pectic polysaccharide from Pseudostellaria heterophylla and stimulating insulin secretion of INS-1 cell and distributing in rats by oral. International journal of biological macromolecules 2018, 106:456-463.
  63. Chen Q, Du Y, Zhang K, Liang Z, Li J, Yu H, Ren R, Feng J, Jin Z, Li F: Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer’s Disease. ACS nano 2018, 12(2):1321-1338.
  64. Chen Y, Vastenhouw B, Wu C, Goorden MC, Beekman FJ: Optimized image acquisition for dopamine transporter imaging with ultra-high resolution clinical pinhole SPECT. Physics in Medicine & Biology 2018, 63(22):225002.
  65. Chen Y-H, Chang K-P, Chu S-C, Yen T-C, Wang L-Y, Chang JT-C, Hsu C-L, Ng S-H, Liu S-H, Chan S-C: Value of early evaluation of treatment response using 18 F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma. European journal of nuclear medicine and molecular imaging 2018:1-11.
  66. Cheng CT, Chen YY, Wu RC, Tsai CY, Chiang KC, Yeh TS, Chen MH, Yeh CN: MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients. Oncology reports 2018, 40(3):1411-1421.
  67. Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G: Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia. Molecular psychiatry 2018, 23(7):1666.
  68. Chiu C-C, Lu C-S, Weng Y-H, Chen Y-L, Huang Y-Z, Chen R-S, Cheng Y-C, Huang Y-C, Liu Y-C, Lai S-C: PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, ER stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model. Molecular neurobiology 2018:1-19.
  69. Chung Y-H, Lu K-Y, Chiu S-C, Lo C-J, Hung L-M, Huang J-P, Cheng M-L, Wang C-H, Tsai C-K, Lin Y-C: Early Imaging Biomarker of Myocardial Glucose Adaptations in High-Fat-Diet-Induced Insulin Resistance Model by Using 18F-FDG PET and [U-13C] glucose Nuclear Magnetic Resonance Tracer. Contrast Media & Molecular Imaging 2018, 2018.
  70. Cleeren E, Casteels C, Goffin K, Koole M, Van Laere K, Janssen P, Van Paesschen W: Positron emission tomography imaging of cerebral glucose metabolism and type 1 cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys. Epilepsia 2018, 59(5):959-970.
  71. Colás L, Domercq M, Ramos‐Cabrer P, Palma A, Gómez‐Vallejo V, Padro D, Plaza‐García S, Pulagam KR, Higuchi M, Matute C: In vivo imaging of α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia. Glia 2018.
  72. Cole LE, McGinnity TL, Irimata LE, Vargo-Gogola T, Roeder RK: Effects of bisphosphonate ligands and PEGylation on targeted delivery of gold nanoparticles for contrast-enhanced radiographic detection of breast microcalcifications. Acta biomaterialia 2018, 82:122-132.
  73. Collignon A-M, Lesieur J, Anizan N, Azzouna RB, Poliard A, Gorin C, Letourneur D, Chaussain C, Rouzet F, Rochefort GY: Early angiogenesis detected by PET imaging with 64Cu-NODAGA-RGD is predictive of bone critical defect repair. Acta biomaterialia 2018, 82:111-121.
  74. Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K: Development and in vivo preclinical imaging of fluorine-18-labeled synaptic vesicle protein 2A (SV2A) PET tracers. Molecular Imaging and Biology 2018:1-10.
  75. Corral A, Balcerzyk M, Gallardo M, Amorim CA, Parrado-Gallego Á, Risco R: An optimized controlled rate slow cooling protocol for bovine ovarian tissue cryopreservation by means of X-ray computed tomography. Theriogenology 2018.
  76. Corral A, Clavero M, Gallardo M, Balcerzyk M, Amorim CA, Parrado-Gallego Á, Dolmans M-M, Paulini F, Morris J, Risco R: Ovarian tissue cryopreservation by stepped vitrification and monitored by X-ray computed tomography. Cryobiology 2018, 81:17-26.
  77. Corral A, López R, Balcerzyk M, Parrado-Gallego Á, Fernández-Gómez I, Olmo A, Risco R: Use of X-Ray Computed Tomography for Ice Detection Applied to Organ Cryopreservation. Biopreservation and biobanking 2018.
  78. Coughlin JM, Du Y, Rosenthal HB, Slania S, Koo SM, Park A, Solomon G, Vranesic M, Antonsdottir I, Speck CL: The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [18F] ASEM. NeuroImage 2018, 165:118-124.
  79. Coughlin JM, Yang T, Rebman AW, Bechtold KT, Du Y, Mathews WB, Lesniak WG, Mihm EA, Frey SM, Marshall ES: Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11 C] DPA-713 PET. Journal of neuroinflammation 2018, 15(1):346.
  80. Crabbé M, Van der Perren A, Weerasekera A, Himmelreich U, Baekelandt V, Van Laere K, Casteels C: Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson’s disease and levodopa-induced dyskinesia. Neurobiology of aging 2018, 61:82-92.
  81. Cui Q, Liu Y, Zhou M, Han Y, Yin C, Bai G: An optimized MicroPET imaging method for the distribution and synergies of natural products. Frontiers in pharmacology 2018, 9.
  82. da Silva N, Lohmann P, Fairney J, Magill A, Peusquens A-MO, Choi C-H, Stirnberg R, Stoffels G, Galldiks N, Golay X: Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI. European journal of nuclear medicine and molecular imaging 2018:1-10.
  83. Dang LC, Samanez-Larkin GR, Castrellon JJ, Perkins SF, Cowan RL, Zald DH: Individual differences in dopamine D 2 receptor availability correlate with reward valuation. Cognitive, Affective, & Behavioral Neuroscience 2018:1-9.
  84. Dang LC, Samanez-Larkin GR, Smith CT, Castrellon JJ, Perkins SF, Cowan RL, Claassen DO, Zald DH: FTO affects food cravings and interacts with age to influence age-related decline in food cravings. Physiology & behavior 2018, 192:188-193.
  85. Dasari PK, Jones JP, Casey ME, Liang Y, Dilsizian V, Smith MF: The effect of time-of-flight and point spread function modeling on 82 Rb myocardial perfusion imaging of obese patients. Journal of Nuclear Cardiology 2018:1-25.
  86. de Laat B, Weerasekera A, Leurquin‐Sterk G, Gsell W, Bormans G, Himmelreich U, Casteels C, Van Laere K: Effects of alcohol exposure on the glutamatergic system: a combined longitudinal 18F‐FPEB and 1H‐MRS study in rats. Addiction biology 2018.
  87. de Lange C, Solberg R, Holtedahl JE, Tulipan A, Barlinn J, Trigg W, Wickstrøm T, Saugstad OD, Malinen E, Revheim ME: Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs. Nuclear medicine and biology 2018, 66:49-57.
  88. de Ligt M, Bruls YM, Hansen J, Habets M-F, Havekes B, Nascimento EB, Moonen-Kornips E, Schaart G, Schrauwen-Hinderling VB, van Marken Lichtenbelt W: Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes. Molecular metabolism 2018, 12:39-47.
  89. De Lombaerde S, Devisscher L, Verhoeven J, Neyt S, Van Vlierberghe H, Vanhove C, De Vos F: Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F] FCA in mouse models of liver disease. Nuclear Medicine and Biology 2018.
  90. De Lombaerde S, Kersemans K, Neyt S, Verhoeven J, Vanhove C, De Vos F: Evaluating Hepatobiliary Transport with 18F-Labeled Bile Acids: The Effect of Radiolabel Position and Bile Acid Structure on Radiosynthesis and In Vitro and In Vivo Performance. Contrast media & molecular imaging 2018, 2018.
  91. De Picker L, Ottoy J, Verhaeghe J, Deleye S, Fransen E, Kosten L, Sabbe B, Coppens V, Timmers M, de Boer P: State-associated changes in longitudinal [18F]-PBR111 TSPO PET Imaging of psychosis patients: evidence for the accelerated ageing hypothesis? Brain, behavior, and immunity 2018.
  92. de Souza GS, da Silva AMM: Investigation of Time-Activity Curve Behavior in Dynamic [11 C]-(R)-PK11195 PET in Cortical Brain Regions: Preliminary Results. In: World Congress on Medical Physics and Biomedical Engineering 2018: 2019: Springer; 2019: 699-702.
  93. Delso G, Kemp B, Kaushik S, Wiesinger F, Sekine T: Improving PET/MR brain quantitation with template-enhanced ZTE. NeuroImage 2018, 181:403-413.
  94. Delvaeye T, Deleye S, Lemeire K, Gonçalves A, Decrock E, Staelens S, Leybaert L, Vandenabeele P, Krysko DV: Noninvasive whole-body imaging of phosphatidylethanolamine as a cell death marker using 99mTc-duramycin during TNF-induced SIRS. Journal of Nuclear Medicine 2018, 59(7):1140-1145.
  95. Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B: Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [18F] GE180 PET quantification. Neuroimage 2018, 165:83-91.
  96. Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B: Data on specificity of [18F] GE180 uptake for TSPO expression in rodent brain and myocardium. Data in Brief 2018, 19:331-336.
  97. Devriese J, Beels L, Maes A, van de Wiele C, Pottel H: Patient-specific lean body mass can be estimated from limited-coverage computed tomography images. Nuclear medicine communications 2018, 39(6):521-526.
  98. Devriese J, Beels L, Maes A, Van de Wiele C, Pottel H: Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria. EJNMMI physics 2018, 5(1):35.
  99. Dewandre D, Atienza M, Sanchez-Espinosa MP, Cantero JL: Effects of PER3 clock gene polymorphisms on aging-related changes of the cerebral cortex. Brain Structure and Function 2018, 223(2):597-607.
  100. Di Ciano P, Tyndale RF, Mansouri E, Hendershot CS, Wilson AA, Lagzdins D, Houle S, Boileau I, Le Foll B: Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers. International Journal of Neuropsychopharmacology 2018, 21(6):503-512.
  101. Di Liberto V, van Dijk RM, Brendel M, Waldron A-M, Möller C, Koska I, Seiffert I, Gualtieri F, Gildehaus FJ, von Ungern-Sternberg B: Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model. Neurobiology of Disease 2018.
  102. Dirckx N, Tower RJ, Mercken EM, Vangoitsenhoven R, Moreau-Triby C, Breugelmans T, Nefyodova E, Cardoen R, Mathieu C, Van der Schueren B: Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism. The Journal of clinical investigation 2018, 128(3).
  103. Dmochowska N, Tieu W, Keller M, Wardill H, Mavrangelos C, Campaniello M, Takhar P, Hughes PA: Immuno-PET of innate immune markers CD11b and IL-1β detect inflammation in murine colitis. Journal of Nuclear Medicine 2018:jnumed. 118.219287.
  104. Doot RK, Dubroff JG, Scheuermann JS, Labban KJ, Cai J, Hsieh C-J, Li S, Lee H, Schubert EK, Hou C: Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18 F] fluortriopride. EJNMMI physics 2018, 5(1):21.
  105. Dubol M, Trichard C, Leroy C, Sandu A-L, Rahim M, Granger B, Tzavara ET, Karila L, Martinot J-L, Artiges E: Dopamine Transporter and Reward Anticipation in a Dimensional Perspective: A Multimodal Brain Imaging Study. Neuropsychopharmacology 2018, 43(4):820.
  106. DuBose LE, Boles Ponto LL, Moser DJ, Harlynn E, Reierson L, Pierce GL: Higher Aortic Stiffness Is Associated With Lower Global Cerebrovascular Reserve Among Older Humans. Hypertension 2018, 72(2):476-482.
  107. DuBose LE, Ponto LLB, Moser DJ, Harlynn E, Reierson L, Pierce GL: Higher Aortic Stiffness Is Associated With Lower Global Cerebrovascular Reserve Among Older Humans. Hypertension 2018:HYPERTENSIONAHA. 118.11143.
  108. Eriksson O, Johnström P, Cselenyi Z, Jahan M, Selvaraju RK, Jensen-Waern M, Takano A, Winzell MS, Halldin C, Skrtic S: In vivo visualization of β-cells by targeting of GPR44. Diabetes 2018, 67(2):182-192.
  109. Faria DdP, Duran FL, Squarzoni P, Coutinho AM, Garcez AT, Santos PP, Brucki SM, de Oliveira MO, Trés ES, Forlenza OV: Topography of 11C-Pittsburgh compound B uptake in Alzheimer’s disease: a voxel-based investigation of cortical and white matter regions. Brazilian Journal of Psychiatry 2018(AHEAD):0-0.
  110. Fenoy AJ, Schulz PE, Selvaraj S, Burrows CL, Zunta-Soares G, Durkin K, Zanotti-Fregonara P, Quevedo J, Soares JC: A longitudinal study on deep brain stimulation of the medial forebrain bundle for treatment-resistant depression. Translational psychiatry 2018, 8(1):111.
  111. Fernandez-Maza L, Egea-Guerrero JJ, Balcerzyk M, Civantos-Jubera G, Gordillo-Escobar E, Vilches-Arenas A, Fernandez-Gomez I, Parrado-Gallego A, Murillo-Cabezas F: Rapid and simplified synthesis of [18F] Fluoromisonidazole and its use in PET imaging in an experimental model of subarachnoid hemorrhage. Applied Radiation and Isotopes 2018, 132:79-84.
  112. Fiorenzato E, Biundo R, Cecchin D, Frigo AC, Kim J, Weis L, Strafella AP, Antonini A: Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson’s Disease: The PPMI Dataset. Journal of Alzheimer’s Disease 2018(Preprint):1-9.
  113. Fjellaksel R, Oteiza A, Martin-Armas M, Riss PJ, Hjelstuen OK, Kuttner S, Hansen JH, Sundset R: First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor. BMC research notes 2018, 11(1):811.
  114. Focke C, Blume T, Zott B, Shi YY, Deussing M, Peters F, Schmidt C, Kleinberger G, Lindner S, Gildehaus F-J: Early and longitudinal microglial activation but not amyloid accumulation predict cognitive outcome in PS2APP mice. Journal of Nuclear Medicine 2018:jnumed. 118.217703.
  115. Follin B, Ghotbi AA, Clemmensen AE, Bentsen S, Juhl M, Søndergaard RH, Lund LD, Haack-Sørensen M, Hasbak P, Cohen S: Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction. Stem cells international 2018, 2018.
  116. Freesmeyer M, Knichel L, Kuehnel C, Winkens T: Stitching of sensor-navigated 3D ultrasound datasets for the determination of large thyroid volumes–a phantom study. Medical ultrasonography 2018, 20(4):480-486.
  117. Frings L, Hellwig S, Bormann T, Spehl TS, Buchert R, Meyer PT: Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer’s dementia in a memory clinic population. European journal of nuclear medicine and molecular imaging 2018, 45(8):1442-1448.
  118. Frisch K, Stimson DH, Venkatachalam T, Pierens GK, Keiding S, Reutens D, Bhalla R: N-(4-[18F] fluorobenzyl) cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: radiosynthesis and proof-of-concept studies in rats. Nuclear medicine and biology 2018, 61:56-62.
  119. Fujimoto A, Hori Y, Nagai Y, Kikuchi E, Oyama K, Suhara T, Minamimoto T: Signaling incentive and drive in the primate ventral pallidum for motivational control of goal-directed action. bioRxiv 2018:420851.
  120. Fukumitsu N, Yeh SH-H, Flores I, Garcia L, Mukhopadhyay U, Young D, Ogawa K, Jeong H-J, Tong W, Gelovani JG: In Vivo 6-([18F] Fluoroacetamido)-1-hexanoicanilide PET Imaging of Altered Histone Deacetylase Activity in Chemotherapy-Induced Neurotoxicity. Contrast media & molecular imaging 2018, 2018.
  121. Gallardo M, Paulini F, Corral A, Balcerzyk M, Lucci CM, Ambroise J, Merola M, Fernandez-maza L, Risco R, Dolmans M-M: Evaluation of a new freezing protocol containing 20% dimethyl sulphoxide concentration to cryopreserve human ovarian tissue. Reproductive biomedicine online 2018, 37(6):653-665.
  122. Galldiks N, Dunkl V, Ceccon G, Tscherpel C, Stoffels G, Law I, Henriksen OM, Muhic A, Poulsen HS, Steger J: Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine. European journal of nuclear medicine and molecular imaging 2018:1-10.
  123. García-García L, de la Rosa RF, Delgado M, Silván Á, Bascuñana P, Bankstahl JP, Gomez F, Pozo MA: Metyrapone prevents acute glucose hypermetabolism and short-term brain damage induced by intrahippocampal administration of 4-aminopyridine in rats. Neurochemistry international 2018, 113:92-106.
  124. García-Lorenzo D, Lavisse S, Leroy C, Wimberley C, Bodini B, Remy P, Veronese M, Turkheimer F, Stankoff B, Bottlaender M: Validation of an automatic reference region extraction for the quantification of [18F] DPA-714 in dynamic brain PET studies. Journal of Cerebral Blood Flow & Metabolism 2018, 38(2):333-346.
  125. Gautier Y, Luneau I, Coquery N, Meurice P, Malbert C-H, Guerin S, Kemp B, Bolhuis JE, Clouard C, Le Huërou-Luron I: Maternal Western diet during gestation and lactation modifies adult offspring’s cognitive and hedonic brain processes, behavior, and metabolism in Yucatan minipigs. The FASEB Journal 2018:fj. 201701541.
  126. Gebhard C, Fiechter M, Herzog BA, Lohmann C, Bengs S, Treyer V, Messerli M, Benz DC, Giannopoulos AA, Gräni C: Sex differences in the long-term prognostic value of 13 N-ammonia myocardial perfusion positron emission tomography. European journal of nuclear medicine and molecular imaging 2018:1-11.
  127. Ghodoosi EK, D’Alessandria C, Li Y, Bartel A, Köhner M, Höllriegl V, Navab N, Eiber M, Li WB, Frey E: The effect of attenuation map, scatter energy window width, and volume of interest on the calibration factor calculation in quantitative 177Lu SPECT imaging: Simulation and phantom study. Physica Medica 2018, 56:74-80.
  128. Giglio J, Zeni M, Savio E, Engler H: Synthesis of an Al 18 F radiofluorinated GLU-UREA-LYS (AHX)-HBED-CC PSMA ligand in an automated synthesis platform. EJNMMI radiopharmacy and chemistry 2018, 3(1):4.
  129. Giubbini R, Peli A, Milan E, Sciagrà R, Camoni L, Albano D, Bertoli M, Bonacina M, Motta F, Statuto M: Comparison between the summed difference score and myocardial blood flow measured by 13 N-ammonia. Journal of Nuclear Cardiology 2018, 25(5):1621-1628.
  130. Gnesin S, Cicone F, Mitsakis P, Van der Gucht A, Baechler S, Miralbell R, Garibotto V, Zilli T, Prior JO: First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68 Ga-NODAGA-MJ9. EJNMMI research 2018, 8(1):108.
  131. Golan S, Nidam M, Bernstine H, Baniel J, Groshar D: Dynamic 11C-Choline PET/CT for the primary diagnosis of prostate cancer. International braz j urol 2018, 44(5):900-905.
  132. Gómez-Pinedo U, Sanchez-Rojas L, Benito-Martin MS, Lendinez C, León-Espinosa G, Rascón-Ramirez FJ, Herrero J, Castro B, Moreno-Jiménez L, del Olmo M: Evaluation of the Safety and Efficacy of the Therapeutic Potential of Adipose-Derived Stem Cells Injected in the Cerebral Ischemic Penumbra. Journal of Stroke and Cerebrovascular Diseases 2018, 27(9):2453-2465.
  133. Gonzalez PS, O’Prey J, Cardaci S, Barthet VJ, Sakamaki J-i, Beaumatin F, Roseweir A, Gay DM, Mackay G, Malviya G: Mannose impairs tumour growth and enhances chemotherapy. Nature 2018, 563(7733):719.
  134. Gonzalez-Mancebo D, Becerro AI, Genevois C, Allix M, Corral A, Parrado-Gallego A, Ocana M: Structural, optical and X-ray attenuation properties of Tb 3+: Ba x Ce 1-x F 3-x (x= 0.18–0.48) nanospheres synthesized in polyol medium. Dalton Transactions 2018.
  135. González-Mancebo D, Becerro AI, Rojas TC, Olivencia A, Corral A, Balcerzyk M, Cantelar E, Cussó F, Ocaña M: Room temperature synthesis of water-dispersible Ln3+: CeF3 (Ln= Nd, Tb) nanoparticles with different morphology as bimodal probes for fluorescence and CT imaging. Journal of colloid and interface science 2018, 520:134-144.
  136. Gosewisch A, Delker A, Tattenberg S, Ilhan H, Todica A, Brosch J, Vomacka L, Brunegraf A, Gildehaus FJ, Ziegler S: Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA 0, Tyr 3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach. EJNMMI research 2018, 8(1):76.
  137. Goutal S, Gerstenmayer M, Auvity S, Caillé F, Mériaux S, Buvat I, Larrat B, Tournier N: Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib. Journal of Controlled Release 2018, 292:210-220.
  138. Grimmer T, Shi K, Diehl-Schmid J, Natale B, Drzezga A, Förster S, Förstl H, Schwaiger M, Yakushev I, Wester H-J: 18 F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases. Molecular psychiatry 2018:1.
  139. Grkovski M, Gharzeddine K, Sawan P, Schöder H, Michaud L, Weber WA, Humm JL: 11C-choline pharmacokinetics in recurrent prostate cancer. Journal of Nuclear Medicine 2018, 59(11):1672-1678.
  140. Grosse GM, Bascuñana P, Schulz-Schaeffer WJ, Teebken OE, Wilhelmi M, Worthmann H, Ross TL, Wester H-J, Kropf S, Derlin T: Targeting Chemokine Receptor CXCR4 and Translocator Protein for Characterization of High-Risk Plaque in Carotid Stenosis Ex Vivo. Stroke 2018, 49(8):1988-1991.
  141. Guo M, Gao Z-G, Tyler R, Stodden T, Li Y, Ramsey J, Zhao W-J, Wang G-J, Wiers CE, Fowler JS: Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging. Journal of Medicinal Chemistry 2018, 61(22):9966-9975.
  142. Haider A, Iten I, Ahmed H, Herder AM, Gruber S, Krämer SD, Keller C, Schibli R, Wünsch B, Mu L: Identification and Preclinical Evaluation of a Radiofluorinated Benzazepine Derivative for Imaging the GluN2B Subunit of the Ionotropic NMDA Receptor. Journal of Nuclear Medicine 2018:jnumed. 118.212134.
  143. Haider A, Spinelli F, Herde AM, Mu B, Keller C, Margelisch M, Weber M, Schibli R, Mu L, Ametamey SM: Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue. European journal of medicinal chemistry 2018, 145:746-759.
  144. Hajdu I, Makhlouf A, Solomon VR, Michel D, Al-Dulaymi M, Wasan KM, Fonge H, Badea I: a 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior. International journal of nanomedicine 2018, 13:7801.
  145. Hamelin L, Lagarde J, Dorothée G, Potier MC, Corlier F, Kuhnast B, Caillé F, Dubois B, Fillon L, Chupin M: Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer’s disease. Brain 2018, 141(6):1855-1870.
  146. Hansson O, Palmqvist S, Ljung H, Cronberg T, van Westen D, Smith R: Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people. Alzheimer’s & Dementia 2018, 14(1):54-61.
  147. Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, Tago T, Tomita N, Watanuki S, Hiraoka K: Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2018, 59(4):671-674.
  148. Hashimoto H, Fukushima Y, Kumita S-i, Tomiyama T, Kiriyama T: Feasibility of myocardial flow reserve prediction without the use of dynamic data from myocardial perfusion positron emission tomography. The international journal of cardiovascular imaging 2018:1-7.
  149. Hashimoto N, Morita K, Tsutsui Y, Himuro K, Baba S, Sasaki M: Time-of-flight information improved the detectability of sub-centimeter sphere using clinical positron emission tomography/computed tomography scanner. Journal of nuclear medicine technology 2018:jnmt. 117.204735.
  150. Hellwig S, Frings L, Bormann T, Vach W, Buchert R, Meyer PT: Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [18 F] FDG PET. European journal of nuclear medicine and molecular imaging 2018:1-12.
  151. Henriksen OM, Vestergaard MB, Lindberg U, Aachmann-Andersen NJ, Lisbjerg K, Christensen SJ, Rasmussen P, Olsen NV, Forman JL, Larsson HBW: Interindividual and regional relationship between cerebral blood flow and glucose metabolism in the resting brain. Journal of Applied Physiology 2018.
  152. Herde AM, Schibli R, Weber M, Ametamey SM: Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients. European journal of nuclear medicine and molecular imaging 2018:1-14.
  153. Hirvonen J, Zanotti-Fregonara P, Gorelick DA, Lyoo CH, Rallis-Frutos D, Morse C, Zoghbi SS, Pike VW, Volkow ND, Huestis MA: Decreased cannabinoid CB1 receptors in male tobacco smokers examined with positron emission tomography. Biological psychiatry 2018, 84(10):715-721.
  154. Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L: Systemic Inflammation and Evidence of a Cardio-splenic Axis in Patients with Psoriasis. Acta dermato-venereologica 2018, 98(3-4):390-395.
  155. Hop H, de Boer S, Reijrink M, Kamphuisen P, de Borst M, Pol R, Zeebregts C, Hillebrands J, Slart R, Boersma H: 18 F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques. Journal of Nuclear Cardiology 2018:1-12.
  156. Hosomi S, Watabe T, Mori Y, Koyama Y, Adachi S, Hoshi N, Ohnishi M, Ogura H, Yoshioka Y, Hatazawa J: Inflammatory projections after focal brain injury trigger neuronal network disruption: An 18F-DPA714 PET study in mice. NeuroImage: Clinical 2018, 20:946-954.
  157. Hovhannisyan N, Fillesoye F, Guillouet S, Ibazizene M, Toutain J, Gourand F, Valable S, Plancoulaine B, Barré L: [18F] Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [18F] FDG in human xenograft models. Theranostics 2018, 8(16):4563.
  158. Hsiao H-Y, Yang C-Y, Liu J-W, Brey EM, Cheng M-H: Periosteal Osteogenic Capacity Depends on Tissue Source. Tissue Engineering 2018(ja).
  159. Hsieh YJ, Wu LC, Ke CC, Chang CW, Kuo JW, Huang WS, Chen FD, Yang BH, Tai HT, Chen SCJ: Effects of the Acute and Chronic Ethanol Intoxication on Acetate Metabolism and Kinetics in the Rat Brain. Alcoholism: Clinical and Experimental Research 2018, 42(2):329-337.
  160. Huang C, Wang Z, Liu L, Liu X, Dong J, Xu Q, Zhang B, Miao L: Predicting the dopamine D2 receptor occupancy of ropinirole in rats using positron emission tomography and pharmacokinetic–pharmacodynamic modeling. Xenobiotica 2018:1-9.
  161. Huang K-L, Hsiao T, Kuo H-C, Hsieh C-J, Hsieh Y-C, Wu Y-M, Wey S-P, Yen T-C, Lin K-J, Huang C-C: Correlation between visual association memory test and structural changes in patients with Alzheimer’s disease and amnestic mild cognitive impairment. Journal of the Formosan Medical Association 2018.
  162. Huang M-H, Chen M-H, Tu P-C, Bai YM, Su T-P, Yang B-H, Liu R-S, Li C-T: Elevated tumor necrosis factor-alpha receptor subtype 1 and the association with abnormal brain function in treatment-resistant depression. Journal of affective disorders 2018, 235:250-256.
  163. Huang S-Y, Hsu J-L, Lin K-J, Liu H-L, Wey S-P, Hsiao T, Initiative AsDN: Characteristic patterns of inter-and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease. Scientific reports 2018, 8.
  164. Huang YC, Farn SS, Chou YC, Yeh CN, Chang CW, Chung YH, Chen TW, Huang WS, Yu CS: Synthesis of para‐[18F] Fluorofenbufen Octylamide for PET Imaging of Brain Tumors. Journal of the Chinese Chemical Society 2018.
  165. Huber G, Hüllner M, Schmid C, Brunner A, Sah B, Vetter D, Kaufmann P, von Schulthess G: Benefit of 18 F-fluorocholine PET imaging in parathyroid surgery. European radiology 2018, 28(6):2700-2707.
  166. Hulsart-Billström G, Selvaraju RK, Estrada S, Lubberink M, Asplund V, Bergman K, Marsell R, Larsson S, Antoni G: Non-invasive tri-modal visualisation via PET/SPECT/μCT of recombinant human bone morphogenetic protein-2 retention and associated bone regeneration: A proof of concept. Journal of Controlled Release 2018.
  167. Hunter RW, Hughey CC, Lantier L, Sundelin EI, Peggie M, Zeqiraj E, Sicheri F, Jessen N, Wasserman DH, Sakamoto K: Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase. Nature medicine 2018, 24(9):1395.
  168. Ikawa M, Kimura H, Kitazaki Y, Sugimoto K, Matsunaga A, Hayashi K, Yamamura O, Tsujikawa T, Hamano T, Yoneda M: Arterial spin labeling MR imaging for the clinical detection of cerebellar hypoperfusion in patients with spinocerebellar degeneration. Journal of the neurological sciences 2018, 394:58-62.
  169. Inoue Ki, Miyachi S, Nishi K, Okado H, Nagai Y, Minamimoto T, Nambu A, Takada M: Recruitment of calbindin into nigral dopamine neurons protects against MPTP‐Induced parkinsonism. Movement Disorders 2018.
  170. Ishibashi K, Miura Y, Wagatsuma K, Toyohara J, Ishiwata K, Ishii K: Occupancy of adenosine A2A receptors by istradefylline in patients with Parkinson’s disease using 11C-preladenant PET. Neuropharmacology 2018, 143:106-112.
  171. Ishikawa A, Tokunaga M, Maeda J, Minamihisamatsu T, Shimojo M, Takuwa H, Ono M, Ni R, Hirano S, Kuwabara S: In vivo visualization of tau accumulation, microglial activation, and brain atrophy in a mouse model of tauopathy rTg4510. Journal of Alzheimer’s Disease 2018, 61(3):1037-1052.
  172. Ishiki A, Harada R, Kai H, Sato N, Totsune T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y: Neuroimaging-pathological correlations of [18 F] THK5351 PET in progressive supranuclear palsy. Acta neuropathologica communications 2018, 6(1):53.
  173. Iwamoto T, Utsumi K, Kobayashi S, Yasumura S, Hatakeyama S, Hayashi A, Kawanishi C: Effect of Memantine on Brain Metabolic Activity and Perfusion in Drug-naïve Moderate Alzheimer’s Disease Patients. Neuropsychiatry (London) 2018, 8(2):546-554.
  174. James GM, Gryglewski G, Vanicek T, Berroterán-Infante N, Philippe C, Kautzky A, Nics L, Vraka C, Godbersen GM, Unterholzner J: Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo. Cerebral Cortex 2018, 29(1):372-382.
  175. Jeong EH, Sunwoo MK, Song YS: Serial I-123-FP-CIT SPECT image findings of Parkinson’s disease patients with levodopa-induced dyskinesia. Frontiers in Neurology 2018, 9:1133.
  176. Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, Fliessbach K, Franke C, Fuentes M, Heneka MT: Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE). Alzheimer’s research & therapy 2018, 10(1):15.
  177. Johansen A, Hansen HD, Svarer C, Lehel S, Leth-Petersen S, Kristensen JL, Gillings N, Knudsen GM: The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [11C] Cimbi-36 labeled in two positions. Journal of Cerebral Blood Flow & Metabolism 2018, 38(4):659-668.
  178. John WS, Martin TJ, Sai KKS, Nader SH, Gage HD, Mintz A, Nader MA: Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability. Journal of Pharmacology and Experimental Therapeutics 2018, 364(2):300-310.
  179. Joo Y-H, Kim J-H, Son Y-D, Kim H-K, Shin Y-J, Lee S-Y, Kim J-H: The relationship between excitement symptom severity and extrastriatal dopamine D 2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [18 F] fallypride. European archives of psychiatry and clinical neuroscience 2018, 268(6):529-540.
  180. Joya A, Padro D, Gómez-Vallejo V, Plaza-García S, Llop J, Martín A: PET Imaging of Crossed Cerebellar Diaschisis after Long-Term Cerebral Ischemia in Rats. Contrast Media & Molecular Imaging 2018, 2018.
  181. Juarez EJ, Castrellon JJ, Green MA, Crawford JL, Seaman KL, Smith CT, Dang LC, Matuskey D, Morris ED, Cowan RL: Reliability of the correlative triad among aging, dopamine D2-like receptor availability, and cognition. bioRxiv 2018:494765.
  182. Kaneko K-i, Tanaka M, Ishii A, Katayama Y, Nakaoka T, Irie S, Kawahata H, Yamanaga T, Wada Y, Miyake T: A clinical quantitative evaluation of hepatobiliary transport of [11C] Dehydropravastatin in humans using positron emission tomography. Drug Metabolism and Disposition 2018:dmd. 118.080408.
  183. Kang JM, Lee J-Y, Kim YK, Sohn BK, Byun MS, Choi JE, Son SK, Im H-J, Lee J-H, Ryu YH: Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer’s Disease in Mild Cognitive Impairment. Molecular diagnosis & therapy 2018:1-9.
  184. Kang Y, Henchcliffe C, Verma A, Vallabhajosula S, He B, Kothari PJ, Pryor KO, Mozley PD: 18F‐FPEB PET/CT Shows mGluR5 Upregulation in Parkinson’s Disease. Journal of Neuroimaging 2018.
  185. Kang Y, Mozley PD, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J: Noninvasive PK11195‐PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson’s Disease. Journal of Neuroimaging 2018.
  186. Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA: Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11] PK11195. PloS one 2018, 13(8):e0201289.
  187. Kanno I, Seki C, Takuwa H, Jin Z-H, Boturyn D, Dumy P, Furukawa T, Saga T, Ito H, Masamoto K: Positron emission tomography of cerebral angiogenesis and TSPO expression in a mouse model of chronic hypoxia. Journal of Cerebral Blood Flow & Metabolism 2018, 38(4):687-696.
  188. Kasanova Z, Ceccarini J, Frank MJ, van Amelsvoort T, Booij J, Heinzel A, Mottaghy FM, Myin-Germeys I: Daily-life stress differentially impacts ventral striatal dopaminergic modulation of reward processing in first-degree relatives of individuals with psychosis. European Neuropsychopharmacology 2018, 28(12):1314-1324.
  189. Kato M, Yokoyama C, Kawasaki A, Takeda C, Koike T, Onoe H, Iriki A: Individual identity and affective valence in marmoset calls: in vivo brain imaging with vocal sound playback. Animal cognition 2018, 21(3):331-343.
  190. Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Hurtado Rua SM, Park C, Gillen KM, Nguyen TD: Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain 2018, 142(1):133-145.
  191. Kawamura K, Yamasaki T, Zhang Y, Wakizaka H, Hatori A, Xie L, Fujinaga M, Zhang M-R: Change in the Binding of [11 C] BU99008 to Imidazoline I 2 Receptor Using Brain PET in Zucker Rats. Molecular Imaging and Biology 2018:1-8.
  192. Kawashima S, Ueki Y, Kato T, Ito K, Matsukawa N: Reduced striatal dopamine release during motor skill acquisition in Parkinson’s disease. PloS one 2018, 13(5):e0196661.
  193. Kessler M, Mamach M, Beutelmann R, Bankstahl J, Bengel F, Klump G, Berding G: Activation in the auditory pathway of the gerbil studied with 18 F-FDG PET: effects of anesthesia. Brain Structure and Function 2018, 223(9):4293-4305.
  194. Kim JH, Cumming P, Son YD, Kim HK, Joo YH, Kim JH: Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [18F] fallypride PET and functional MRI study. Synapse 2018, 72(12):e22064.
  195. Kim J-H, Joo Y-H, Son Y-D, Kim J-H, Kim Y-K, Kim H-K, Lee S-Y, Ido T: In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression. European Neuropsychopharmacology 2018.
  196. Kim K-M, Zamaleeva AI, Lee YW, Ahmed MR, Kim E, Lee H-R, Pothineni VR, Tao J, Rhee S, Jayakumar M: Characterization of brain dysfunction induced by bacterial lipopeptides that alter neuronal activity and network in rodent brains. Journal of Neuroscience 2018, 38(50):10672-10691.
  197. Kim M-J, Shrestha SS, Cortes M, Singh P, Morse C, Liow J-S, Gladding RL, Brouwer C, Henry K, Gallagher E: Evaluation of Two Potent and Selective PET Radioligands to Image COX-1 and COX-2 in Rhesus Monkeys. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2018.
  198. Kim R, Lee J, Kim Y, Kim A, Jang M, Kim H-J, Jeon B, Kang UJ, Fahn S: Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson’s disease: An analysis of the PPMI cohort. Parkinsonism & related disorders 2018.
  199. Kim SW, Wiers CE, Tyler R, Shokri-Kojori E, Jang YJ, Zehra A, Freeman C, Ramirez V, Lindgren E, Miller G: Influence of alcoholism and cholesterol on TSPO binding in brain: PET [11 C] PBR28 studies in humans and rodents. Neuropsychopharmacology 2018:1.
  200. King A, Doepner A, Turton D, Ciobota DM, Da Pieve C, Te Fong A-CW, Kramer-Marek G, Chung Y-L, Smith G: Radiosynthesis of the anticancer nucleoside analogue Trifluridine using an automated 18 F-trifluoromethylation procedure. Organic & biomolecular chemistry 2018, 16(16):2986-2996.
  201. Kiraga Ł, Cheda Ł, Taciak B, Różańska K, Tonecka K, Szulc A, Kilian K, Gorka E, Rogulski Z, Rygiel TP: Changes in hypoxia level of CT26 tumors during various stages of development and comparing different methods of hypoxia determination. PloS one 2018, 13(11):e0206706.
  202. Kitamura S, Shimada H, Niwa F, Endo H, Shinotoh H, Takahata K, Kubota M, Takado Y, Hirano S, Kimura Y: Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2018:jnnp-2018-317970.
  203. Klawonn AM, Fritz M, Nilsson A, Bonaventura J, Shionoya K, Mirrasekhian E, Karlsson U, Jaarola M, Granseth B, Blomqvist A: Motivational valence is determined by striatal melanocortin 4 receptors. The Journal of clinical investigation 2018, 128(7).
  204. Knešaurek K, Warnock G, Kostakoglu L, Burger C: Comparison of standardized uptake value ratio calculations in amyloid positron emission tomography brain imaging. World journal of nuclear medicine 2018, 17(1):21.
  205. Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Haase A-M, Svendsen KB, Otto M, Østergaard K, Krogh K, Borghammer P: Objective intestinal function in patients with idiopathic REM sleep behavior disorder. Parkinsonism & related disorders 2018.
  206. Ko K-Y, Wang S-Y, Yen R-F, Shiau Y-C, Hsu J-C, Tsai H-Y, Lee C-L, Chiu K-M, Wu Y-W: Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy. Journal of Nuclear Cardiology 2018:1-11.
  207. Kobayashi R, Hayashi H, Kawakatsu S, Ishiki A, Okamura N, Arai H, Otani K: [18 F] THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review. BMC neurology 2018, 18(1):109.
  208. Konings G, Saarinen N, Delvoux B, Kooreman L, Koskimies P, Krakstad C, Fasmer K, Haldorsen I, Zaffagnini A, Häkkinen M: Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure. International journal of molecular sciences 2018, 19(9):2547.
  209. Kosten L, Deleye S, Stroobants S, Wyffels L, Mingote S, Rayport S, Staelens S: Molecular Imaging of mGluR5 Availability with [11 C] ABP68 in Glutaminase Heterozygous Mice. Cellular and molecular neurobiology 2018:1-9.
  210. Kosten L, Verhaeghe J, Wyffels L, Stroobants S, Staelens S: Acute Ketamine Infusion in Rat Does Not Affect In Vivo [11C] ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5. Molecular imaging 2018, 17:1536012118788636.
  211. Kotsougiani D, Hundepool CA, Bulstra LF, Friedrich PF, Shin AY, Bishop AT: Bone vascularized composite allotransplantation model in swine tibial defect: Evaluation of surgical angiogenesis and transplant viability. Microsurgery 2018.
  212. Kovacs ZI, Papadakis GZ, Tu T-W, Sinharay S, Reid WC, Lewis B, Hammoud DA, Frank JA: Therapeutic Ultrasound Conference 2017. Journal of Therapeutic Ultrasound 2018, 6(1):O1.
  213. Krämer SD, Betzel T, Mu L, Haider A, Herde AM, Boninsegni AK, Keller C, Szermerski M, Schibli R, Wünsch B: Evaluation of 11C-Me-NB1 as a potential PET radioligand for measuring GluN2B-containing NMDA receptors, drug occupancy, and receptor cross talk. Journal of Nuclear Medicine 2018, 59(4):698-703.
  214. Kranz GS, Hahn A, Kraus C, Spies M, Pichler V, Jungwirth J, Mitterhauser M, Wadsak W, Windischberger C, Kasper S: Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers. NeuroImage 2018, 171:1-5.
  215. Krishnan HS, Bernard-Gauthier V, Placzek MS, Dahl K, Narayanaswami V, Livni E, Chen Z, Yang J, Collier TL, Ran C: Metal Protein-Attenuating Compound for PET Neuroimaging: Synthesis and Preclinical Evaluation of [11C] PBT2. Molecular pharmaceutics 2018, 15(2):695-702.
  216. Kuehnel C, Winkens T, Freesmeyer M: Design, Construction, and Validation of a Hybrid Phantom for Nuclear Medicine and Ultrasound Fusion Imaging. Applied Radiation and Isotopes 2018.
  217. Kumata K, Zhang Y, Fujinaga M, Ohkubo T, Mori W, Yamasaki T, Hanyu M, Xie L, Hatori A, Zhang M-R: [18F] DAA1106: Automated radiosynthesis using spirocyclic iodonium ylide and preclinical evaluation for positron emission tomography imaging of translocator protein (18 kDa). Bioorganic & medicinal chemistry 2018, 26(17):4817-4822.
  218. Kuo H-T, Merkens H, Zhang Z, Uribe CF, Lau J, Zhang C, Colpo N, Lin K-S, Benard F: Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies. Molecular pharmaceutics 2018, 15(11):5183-5191.
  219. Kwon Y-D, Kang S, Park H, Cheong I-k, Chang K-A, Lee S-Y, Jung JH, Lee BC, Lim ST, Kim H-K: Novel potential pyrazolopyrimidine based translocator protein ligands for the evaluation of neuroinflammation with PET. European journal of medicinal chemistry 2018, 159:292-306.
  220. Laffon E, Calcagni M, Galli G, Giordano A, Capotosti A, Marthan R, Indovina L: Comparison of three-parameter kinetic model analysis to standard Patlak’s analysis in 18 F-FDG PET imaging of lung cancer patients. EJNMMI research 2018, 8(1):24.
  221. Lahesmaa M, Eriksson O, Gnad T, Oikonen V, Bucci M, Hirvonen J, Koskensalo K, Teuho J, Niemi T, Taittonen M: Cannabinoid Type 1 Receptors are Upregulated During Acute Activation of Brown Adipose Tissue. Diabetes 2018:db171366.
  222. Lai M, Lanz B, Poitry-Yamate C, Romero JF, Berset CM, Cudalbu C, Gruetter R: In vivo 13C MRS in the mouse brain at 14.1 Tesla and metabolic flux quantification under infusion of [1, 6-13C2] glucose. Journal of Cerebral Blood Flow & Metabolism 2018, 38(10):1701-1714.
  223. Laurans L, Venteclef N, Haddad Y, Chajadine M, Alzaid F, Metghalchi S, Sovran B, Denis RG, Dairou J, Cardellini M: Genetic deficiency of indoleamine 2, 3-dioxygenase promotes gut microbiota-mediated metabolic health. Nature Medicine 2018:1.
  224. Laymon CM, Minhas DS, Becker CR, Matan C, Oborski MJ, Price JC, Mountz JM: Image-Based 2D Re-Projection for Attenuation Substitution in PET Neuroimaging. Molecular Imaging and Biology 2018:1-9.
  225. Le Floc’h J, Zlitni A, Bilton HA, Yin M, Farhadi A, Janzen NR, Shapiro MG, Valliant JF, Foster FS: In vivo Biodistribution of Radiolabeled Acoustic Protein Nanostructures. Molecular Imaging and Biology 2018, 20(2):230-239.
  226. Lee J, Ahn S, Lee HA, Won KS, Chang HW, Oh JS, Kim HW: Dietary intake of pantothenic acid is associated with cerebral amyloid burden in patients with cognitive impairment. Food & Nutrition Research 2018, 62.
  227. Lee J-H, Lee M, Park J-A, Ryu YH, Lee KC, Kim KM, Choi JY: Effects of hypothyroidism on serotonin 1A receptors in the rat brain. Psychopharmacology 2018, 235(3):729-736.
  228. Lee M, Lee H-J, Park IS, Park J-A, Kwon YJ, Ryu YH, Kim CH, Kang JH, Hyun IY, Lee KC: Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer. Neuropharmacology 2018, 133:512-517.
  229. Lesniak WG, Chu C, Jablonska A, Du Y, Pomper MG, Walczak P, Janowski M: PET imaging of intra-arterial 89Zr bevacizumab in mice with and without osmotic opening of the blood-brain barrier: distinct advantage of intra-arterial delivery. Journal of Nuclear Medicine 2018:jnumed. 118.218792.
  230. Leurquin-Sterk G, Ceccarini J, Crunelle CL, de Laat B, Verbeek J, Deman S, Neels H, Bormans G, Peuskens H, Van Laere K: Lower limbic metabotropic glutamate receptor 5 availability in alcohol dependence. Journal of Nuclear Medicine 2018, 59(4):682-690.
  231. Leurquin‐Sterk G, Ceccarini J, Crunelle CL, Weerasekera A, de Laat B, Himmelreich U, Bormans G, Van Laere K: Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study. Addiction biology 2018, 23(3):931-944.
  232. Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G: Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer’s disease. Alzheimer’s & Dementia 2018, 14(5):652-663.
  233. Li C-T, Chen M-H, Juan C-H, Liu R-S, Lin W-C, Bai Y-M, Su T-P: Effects of prefrontal theta-burst stimulation on brain function in treatment-resistant depression: A randomized sham-controlled neuroimaging study. Brain stimulation 2018.
  234. Li D, Cheng S, Zou S, Zhu D, Zhu T, Wang P, Zhu X: Immuno-PET imaging of 89Zr labeled anti-PD-L1 domain antibody. Molecular pharmaceutics 2018, 15(4):1674-1681.
  235. Li Y-Y, Zhang B, Yu K-W, Li C, Xie H-Y, Bao W-Q, Kong Y-Y, Jiao F-Y, Guan Y-H, Bai Y-L: Effects of constraint-induced movement therapy on brain glucose metabolism in a rat model of cerebral ischemia: a micro PET/CT study. International Journal of Neuroscience 2018, 128(8):736-745.
  236. Lillethorup TP, Glud AN, Alstrup AK, Mikkelsen TW, Nielsen EH, Zaer H, Doudet DJ, Brooks DJ, Sørensen JCH, Orlowski D: Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs. Experimental neurology 2018, 303:142-152.
  237. Lillethorup TP, Glud AN, Alstrup AK, Noer O, Nielsen EH, Schacht AC, Landeck N, Kirik D, Orlowski D, Sørensen JCH: Longitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigs. Scientific reports 2018, 8(1):15715.
  238. Lillethorup TP, Glud AN, Landeck N, Alstrup AKO, Jakobsen S, Vang K, Doudet DJ, Brooks DJ, Kirik D, Hinz R: In vivo quantification of glial activation in minipigs overexpressing human α‐synuclein. Synapse 2018, 72(12):e22060.
  239. Lin G, Lin K-J, Wang F, Chen T-C, Yen T-C, Yeh T-S: Synergistic anti-proliferative effect of mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity. Disease models & mechanisms 2018:dmm. 033050.
  240. Lin PY, Chiu YL, Huang JH, Chuang EY, Mi FL, Lin KJ, Juang JH, Sung HW, Leong KW: Oral Nonviral Gene Delivery for Chronic Protein Replacement Therapy. Advanced Science 2018:1701079.
  241. Lindbo S, Garousi J, Mitran B, Vorobyeva A, Oroujeni M, Orlova A, Hober S, Tolmachev V: Optimized molecular design of ADAPT-based HER2-imaging probes labelled with 111In and 68Ga. Molecular pharmaceutics 2018.
  242. Lindemann M, Hinz S, Deuther-Conrad W, Namasivayam V, Dukic-Stefanovic S, Teodoro R, Toussaint M, Kranz M, Juhl C, Steinbach J: Radiosynthesis and in vivo evaluation of a fluorine-18 labeled pyrazine based radioligand for PET imaging of the adenosine A2B receptor. Bioorganic & medicinal chemistry 2018, 26(16):4650-4663.
  243. Linnman C, Catana C, Petkov MP, Chonde DB, Becerra L, Hooker J, Borsook D: Molecular and functional PET-fMRI measures of placebo analgesia in episodic migraine: Preliminary findings. NeuroImage: Clinical 2018, 17:680-690.
  244. Liow J-S, Morse C, Lu S, Frankland M, Tye G, Zoghbi S, Gladding R, Shaik A, Innis R, Newman A: [O-methyl-11C] N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl) butyl)-1H-indole-2-carboxamide ([11C] BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D3 Receptors in Rodents and Monkey. Molecules 2018, 23(11):2737.
  245. Liu M, Chen X, Paranjpe M, Zhao Q, Leal J, Wang R, Smith G, Pomper M, Wong D, Zhou Y: Quantitative imaging APOE4 effects on brain tau deposition and glucose metabolism in mild cognitive impairment patients with [18F] AV1451 and [18F] FDG PET. Journal of Nuclear Medicine 2018, 59(supplement 1):80-80.
  246. Lohmann P, Kocher M, Ceccon G, Bauer EK, Stoffels G, Viswanathan S, Ruge MI, Neumaier B, Shah NJ, Fink GR: Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis. NeuroImage: Clinical 2018, 20:537-542.
  247. Lohmann P, Lerche C, Bauer EK, Steger J, Stoffels G, Blau T, Dunkl V, Kocher M, Viswanathan S, Filss CP: Predicting IDH genotype in gliomas using FET PET radiomics. Scientific reports 2018, 8(1):13328.
  248. Lohmann P, Piroth MD, Sellhaus B, Weis J, Geisler S, Oros-Peusquens A-M, Mohlberg H, Amunts K, Shah NJ, Galldiks N: Correlation of Dynamic O-(2-[18F] Fluoroethyl)-L-Tyrosine Positron Emission Tomography, Conventional Magnetic Resonance Imaging, and Whole-Brain Histopathology in a Pretreated Glioblastoma: A Postmortem Study. World neurosurgery 2018, 119:e653-e660.
  249. Lohmann P, Stavrinou P, Lipke K, Bauer EK, Ceccon G, Werner J-M, Neumaier B, Fink GR, Shah NJ, Langen K-J: FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma. European journal of nuclear medicine and molecular imaging 2018:1-12.
  250. Lokitz SJ, Garg S, Nazih R, Garg PK: Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[18 F] Fluorobenzylguanidine: Biodistribution and Radiation Dosimetry. Molecular Imaging and Biology 2018:1-10.
  251. López-González FJ, Paredes-Pacheco J, Thurnhofer-Hemsi K, Rossi C, Enciso M, Toro-Flores D, Murcia-Casas B, Gutiérrez-Cardo AL, Roé-Vellvé N: QModeling: a Multiplatform, Easy-to-Use and Open-Source Toolbox for PET Kinetic Analysis. Neuroinformatics 2018:1-12.
  252. Luo S, Kong X, Wu JR, Wang CY, Tian Y, Zheng G, Su YY, Lu GM, Zhang LJ, Yang GF: Neuroinflammation in acute hepatic encephalopathy rats: imaging and therapeutic effectiveness evaluation using 11 C-PK11195 and 18 F-DPA-714 micro-positron emission tomography. Metabolic brain disease 2018:1-10.
  253. Madru R, Budassi M, Benveniste H, Lee H, Smith SD, Schlyer DJ, Vaska P, Knutsson L, Strand S-E: Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free 64Cu-Labeled Nanoparticles. Cancer biotherapy & radiopharmaceuticals 2018, 33(6):213-220.
  254. Maldonado-Lasuncion I, Atienza M, Sanchez-Espinosa MP, Cantero JL: Aging-Related Changes in Cognition and Cortical Integrity are Associated With Serum Expression of Candidate MicroRNAs for Alzheimer Disease. Cerebral Cortex 2018.
  255. Malik S, Jacobs M, Cho S-S, Boileau I, Blumberger D, Heilig M, Wilson A, Daskalakis ZJ, Strafella AP, Zangen A: Deep TMS of the insula using the H-coil modulates dopamine release: a crossover [11 C] PHNO-PET pilot trial in healthy humans. Brain imaging and behavior 2018, 12(5):1306-1317.
  256. Mamach M, Kessler M, Bankstahl JP, Wilke F, Geworski L, Bengel FM, Kurt S, Berding G: Visualization of the auditory pathway in rats with 18F-FDG PET activation studies based on different auditory stimuli and reference conditions including cochlea ablation. PloS one 2018, 13(10):e0205044.
  257. Mandlik SK, Ranpise NS, Mohanty BS, Chaudhari PR: A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers. Drug delivery and translational research 2018, 8(3):797-805.
  258. Mandrup CM, Egelund J, Nyberg M, Enevoldsen LH, Kjær A, Clemmensen AE, Christensen AN, Suetta C, Frikke-Schmidt R, Steenberg DE: Effects of menopause and high-intensity training on insulin sensitivity and muscle metabolism. Menopause 2018, 25(2):165-175.
  259. Mann T, Kurth J, Hawlitschka A, Stenzel J, Lindner T, Polei S, Hohn A, Krause BJ, Wree A: [18F] fallypride-PET/CT Analysis of the Dopamine D2/D3 Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection. Molecules 2018, 23(3):587.
  260. Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell‐Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ: The Parkinson’s progression markers initiative (PPMI)–establishing a PD biomarker cohort. Annals of Clinical and Translational Neurology 2018, 5(12):1460-1477.
  261. Marín-Royo G, Gallardo I, Martínez-Martínez E, Gutiérrez B, Jurado-López R, López-Andrés N, Gutiérrez-Tenorio J, Rial E, Bartolomé MaV, Nieto ML: Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity. Disease models & mechanisms 2018:dmm. 032086.
  262. Matsusaka Y, Nakahara T, Takahashi K, Iwabuchi Y, Ogata Y, Nishime C, Kajimura M, Jinzaki M: Preclinical evaluation of heat-denatured [18F] FDG-labeled red blood cells for detecting splenic tissues with PET in rats. Nuclear medicine and biology 2018, 56:26-30.
  263. Mauler J, Maudsley AA, Langen K-J, Nikoubashman O, Stoffels G, Sheriff S, Lohmann P, Filss C, Galldiks N, Kops ER: Spatial Relationship of Glioma Volume Derived from 18F-FET PET and Volumetric MR Spectroscopy Imaging: A Hybrid PET/MRI Study. Journal of Nuclear Medicine 2018, 59(4):603-609.
  264. McGowan DR, Skwarski M, Papiez BW, Macpherson RE, Gleeson FV, Schnabel JA, Higgins GS, Fenwick JD: Whole tumor kinetics analysis of 18 F-fluoromisonidazole dynamic PET scans of non-small cell lung cancer patients, and correlations with perfusion CT blood flow. EJNMMI research 2018, 8(1):73.
  265. McGraw T, Guayaquil-Sosa A: Hybrid rendering of exploded views for medical image atlas visualization. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2018, 6(6):668-677.
  266. Mendoza-Figueroa MJ, Escudero-Castellanos A, Ramirez-Nava GJ, Ocampo-García BE, Santos-Cuevas CL, Ferro-Flores G, Pedraza-Lopez M, Avila-Rodriguez MA: Preparation and preclinical evaluation of 68 Ga-iPSMA-BN as a potential heterodimeric radiotracer for PET-imaging of prostate cancer. Journal of Radioanalytical and Nuclear Chemistry 2018, 318(3):2097-2105.
  267. Michaelides M, Miller ML, Egervari G, Primeaux SD, Gomez JL, Ellis RJ, Landry JA, Szutorisz H, Hoffman AF, Lupica CR: Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity. Molecular psychiatry 2018:1.
  268. Mignion L, Schmitz S, Michoux N, Caignet X, Goebbels R-M, Bol A, Neveu M-AC, Grégoire V, Duprez T, Lhommel R: 2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck. Oncotarget 2018, 9(47):28572.
  269. Milara J, Díaz-Platas L, Contreras S, Ribera P, Roger I, Ballester B, Montero P, Cogolludo Á, Morcillo E, Cortijo J: MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease. Respiratory research 2018, 19(1):226.
  270. Miranda A, Glorie D, Bertoglio D, Vleugels J, Debruyne G, Stroobants S, Staelens S, Verhaeghe J: Awake 18F-FDG PET imaging of memantine-induced brain activation and test-retest in freely running mice. Journal of Nuclear Medicine 2018:jnumed. 118.218669.
  271. Missault S, Anckaerts C, Blockx I, Deleye S, Van Dam D, Barriche N, De Pauw G, Aertgeerts S, Valkenburg F, De Deyn PP: Neuroimaging of subacute brain inflammation and microstructural changes predicts long-term functional outcome after experimental traumatic brain injury. Journal of neurotrauma 2018.
  272. Miyajima N, Ito M, Rokugawa T, Iimori H, Momosaki S, Omachi S, Shimosegawa E, Hatazawa J, Abe K: Detection of neuroinflammation before selective neuronal loss appearance after mild focal ischemia using [18 F] DPA-714 imaging. EJNMMI research 2018, 8(1):43.
  273. Moeller SJ, Okita K, Robertson CL, Ballard ME, Konova AB, Goldstein RZ, Mandelkern MA, London ED: Low striatal dopamine D2-type receptor availability is linked to simulated drug choice in methamphetamine users. Neuropsychopharmacology 2018, 43(4):751.
  274. Monazzam A, Lau J, Velikyan I, Li S-C, Razmara M, Rosenström U, Eriksson O, Skogseid B: Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [68 Ga] Ga-DO3A-VS-Cys 40-Exendin-4/PET. Scientific reports 2018, 8(1):748.
  275. Moreno JM, Tapia A, Martinez CM, Reverte V, Oltra L, Llinas MT, Salazar FJ: Sex-dependent differences in the adverse renal changes induced by an early in life exposure to a high fat diet. American Journal of Physiology-Renal Physiology 2018.
  276. Mukai H, Hatanaka K, Yagi N, Warashina S, Zouda M, Takahashi M, Narushima K, Yabuuchi H, Iwano J, Kuboyama T: Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis. Journal of Controlled Release 2018.
  277. Mukherjee J, Lao PJ, Betthauser TJ, Samra GK, Pan Ml, Patel IH, Liang C, Metherate R, Christian BT: Human brain imaging of nicotinic acetylcholine α4β2* receptors using [18 F] N ifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways. Journal of Comparative Neurology 2018, 526(1):80-95.
  278. Müller Herde A, Boss S, He Y, Schibli R, Mu L, Ametamey S: Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F] PSS232 in the Rat Brain. Pharmaceuticals 2018, 11(3):83.
  279. Musafargani S, Ghosh KK, Mishra S, Mahalakshmi P, Padmanabhan P, Gulyás B: PET/MRI: a frontier in era of complementary hybrid imaging. European journal of hybrid imaging 2018, 2(1):12.
  280. Nam SB, Kim K, Kim BS, Im H-J, Lee SH, Kim S-J, Kim IJ, Pak K: The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters. Scientific reports 2018, 8(1):4924.
  281. Napieczynska H, Kolb A, Katiyar P, Tonietto M, Ud-Dean M, Stumm R, Herfert K, Calaminus C, Pichler BJ: Impact of the Arterial Input Function Recording Method on Kinetic Parameters in Small-Animal PET. Journal of Nuclear Medicine 2018, 59(7):1159-1164.
  282. Nasrallah IM, Chen YJ, Hsieh M-K, Phillips JS, Ternes K, Stockbower GE, Sheline Y, McMillan CT, Grossman M, Wolk DA: 18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2018, 59(2):299-306.
  283. Neyrinck K, Breuls N, Holvoet B, Oosterlinck W, Wolfs E, Vanbilloen H, Gheysens O, Duelen R, Gsell W, Lambrichts I: The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction. Theranostics 2018, 8(10):2799.
  284. Nguyen DL, Wimberley C, Truillet C, Jego B, Caillé F, Pottier G, Boisgard R, Buvat I, Bouilleret V: Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows. Epilepsia 2018, 59(6):1234-1244.
  285. Ni R, Ji B, Ono M, Sahara N, Zhang M-R, Aoki I, Nordberg A, Suhara T, Higuchi M: Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models. Journal of Nuclear Medicine 2018:jnumed. 117.201632.
  286. Nicolas CT, Hickey RD, Allen KL, Du Z, Guthman RM, Kaiser RA, Amiot B, Bansal A, Pandey MK, Suksanpaisan L: Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models. Surgery 2018.
  287. Nielsen BD, Gormsen LC, Hansen IT, Keller KK, Therkildsen P, Hauge E-M: Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. European journal of nuclear medicine and molecular imaging 2018, 45(7):1119-1128.
  288. Nikolaus S, Wittsack H-J, Beu M, Antke C, De Souza Silva MA, Wickrath F, Müller-Lutz A, Huston JP, Antoch G, Müller H-W: GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain. Frontiers in behavioral neuroscience 2018, 12:38.
  289. Nishii R, Higashi T, Kagawa S, Okuyama C, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y: 18 F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18 F-FPYBF-2 PET imaging. Annals of nuclear medicine 2018, 32(4):256-263.
  290. Nkoulou R, Fuchs T, Pazhenkottil AP, Wolfrum M, Buechel RR, Gaemperli O, Kaufmann PA: High efficiency gamma camera enables ultra-low fixed dose stress/rest myocardial perfusion imaging. European Heart Journal-Cardiovascular Imaging 2018.
  291. Nonose Y, Gewehr PE, Almeida RF, da Silva JS, Bellaver B, Martins LA, Zimmer ER, Greggio S, Venturin GT, Da Costa JC: Cortical bilateral adaptations in rats submitted to focal cerebral ischemia: emphasis on glial metabolism. Molecular neurobiology 2018, 55(3):2025-2041.
  292. Nummenmaa L, Saanijoki T, Tuominen L, Hirvonen J, Tuulari JJ, Nuutila P, Kalliokoski K: μ-opioid receptor system mediates reward processing in humans. Nature communications 2018, 9(1):1500.
  293. Okuno T, Kawai K, Koyama K, Takahashi M, Ishihara S, Momose T, Morikawa T, Fukayama M, Watanabe T: Value of FDG–PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer. Diseases of the Colon & Rectum 2018, 61(3):320-327.
  294. Oliveira FP, Faria DB, Costa DC, Castelo-Branco M, Tavares JMR: Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123 I] FP-CIT SPECT images. European journal of nuclear medicine and molecular imaging 2018, 45(6):1052-1062.
  295. Olsen M, Aguilar X, Sehlin D, Fang XT, Antoni G, Erlandsson A, Syvänen S: Astroglial responses to amyloid-beta progression in a mouse model of Alzheimer’s disease. Molecular Imaging and Biology 2018:1-10.
  296. Ooms M, Tsujikawa T, Lohith TG, Mabins SN, Zoghbi SS, Sumitomo A, Jaaro-Peled H, Kimura Y, Telu S, Pike VW: [11C](R)-Rolipram positron emission tomography detects DISC1 inhibition of phosphodiesterase type 4 in live Disc1 locus-impaired mice. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18758997.
  297. Ottoy J, De Picker L, Verhaeghe J, Deleye S, Kosten L, Sabbe B, Coppens V, Timmers M, Van Nueten L, Ceyssens S: 18F-PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test–Retest Reproducibility and Quantification of Neuroinflammation. Journal of Nuclear Medicine 2018, 59(8):1267-1274.
  298. Pak K, Kim BS, Kim K, Kim IJ, Jun S, Jeong YJ, Shim HK, Kim S-D, Cho K-S: Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis. American journal of otolaryngology 2018, 39(1):1-5.
  299. Pak K, Kim K, Lee MJ, Lee JM, Kim BS, Kim S-J, Kim IJ: Correlation between the availability of dopamine transporter and olfactory function in healthy subjects. European radiology 2018, 28(4):1756-1760.
  300. Pak K, Kim K, Lee MJ, Lee JM, Kim BS, Kim S-J, Kim IJ: Prediction of future weight change with the dopamine transporter. Brain imaging and behavior 2018:1-6.
  301. Pak K, Nam H-Y, Shin S, Kim K, Lee MJ, Kim E-J, Lee JM, Kim S-J, Kim IJ: Effects of rs591323 on serotonin transporter availability in healthy male subjects. Annals of nuclear medicine 2018:1-6.
  302. Pak K, Shin HK, Kim E-J, Lee J-H, Lyoo CH, Son J, Lee MJ: Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson’s disease. Parkinsonism & related disorders 2018.
  303. Palard-Novello X, Blin A-L, Bourhis D, Garin E, Salaün P-Y, Devillers A, Querellou S, Bourguet P, Le Jeune F, Saint-Jalmes H: Comparison of choline influx from dynamic 18 F-Choline PET/CT and clinicopathological parameters in prostate cancer initial assessment. Annals of nuclear medicine 2018, 32(4):281-287.
  304. Palard-Novello X, Blin A-L, Le Jeune F, Garin E, Salaün P-Y, Devillers A, Gambarota G, Querellou S, Bourguet P, Saint-Jalmes H: Optimization of temporal sampling for 18 F-choline uptake quantification in prostate cancer assessment. EJNMMI research 2018, 8(1):49.
  305. Palmieri L, Elvas F, Vangestel C, Pak K, Gray B, Stroobants S, Staelens S: [99mTc] duramycin for cell death imaging: Impact of kit formulation, purification and species difference. Nuclear medicine and biology 2018, 56:1-9.
  306. Park S, Ha S, Lee S-H, Paeng JC, Keam B, Kim TM, Kim D-W, Heo DS: Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor. PloS one 2018, 13(1):e0189766.
  307. Paul S, Gallagher E, Liow J-S, Mabins S, Henry K, Zoghbi SS, Gunn RN, Kreisl WC, Richards EM, Zanotti-Fregonara P: Building a database for brain 18 kDa translocator protein imaged using [11C] PBR28 in healthy subjects. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18771250.
  308. Pauwelyn G, Laeken NV, Verhoeven J, De Vos F, Peremans K, Dockx R, Baeken C, Descamps B, Vanhove C, Kersemans K: The Signature of the Serotonin System in the Chronic Corticosterone Depression Model: A Study with [18F] MPPF,[18F] Altanserin and [11C] DASB. Neuropsychiatry 2018, 8(04):1377-1390.
  309. Perez-Liva M, Viel T, Yoganathan T, Garofalakis A, Sourdon J, Facchin C, Tanter M, Provost J, Tavitian B: Performance evaluation of the PET component of a hybrid PET/CT-ultrafast ultrasound imaging instrument. Physics in Medicine & Biology 2018, 63(19):19NT01.
  310. Petrik M, Umlaufova E, Raclavsky V, Palyzova A, Havlicek V, Haas H, Novy Z, Dolezal D, Hajduch M, Decristoforo C: Imaging of Pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography. Scientific reports 2018, 8(1):15698.
  311. Pettorruso M, Martinotti G, Cocciolillo F, De Risio L, Cinquino A, Di Nicola M, Camardese G, Migliara G, Moccia L, Conte E: Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123I‐FP‐CIT SPECT study. Addiction biology 2018.
  312. Pohl JM, Volke JK, Thiebes S, Brenzel A, Fuchs K, Beziere N, Ehrlichmann W, Pichler BJ, Squire A, Gueler F: CCR2‐dependent Gr1high monocytes promote kidney injury in shiga toxin‐induced hemolytic uremic syndrome in mice. European journal of immunology 2018.
  313. Polinder-Bos HA, Elting JWJ, Aries MJ, García DV, Willemsen AT, van Laar PJ, Kuipers J, Krijnen WP, Slart RH, Luurtsema G: Changes in cerebral oxygenation and cerebral blood flow during hemodialysis–A simultaneous near-infrared spectroscopy and positron emission tomography study. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18818652.
  314. Polinder-Bos HA, García DV, Kuipers J, Elting JWJ, Aries MJ, Krijnen WP, Groen H, Willemsen AT, van Laar PJ, Strijkert F: Hemodialysis induces an acute decline in cerebral blood flow in elderly patients. Journal of the American Society of Nephrology 2018, 29(4):1317-1325.
  315. Ponto LLB: Principles and Potential Role in Understanding Brain Function. The Wiley Handbook on the Aging Mind and Brain 2018:164.
  316. Ponto LLB, Huang J, Walsh SA, Acevedo MR, Mundt C, Sunderland J, Donovan M: Demonstration of nucleoside transporter activity in the nose-to-brain distribution of [18 F] Fluorothymidine using PET imaging. The AAPS journal 2018, 20(1):16.
  317. Ponto LLB, Walsh S, Huang J, Mundt C, Thede-Reynolds K, Watkins GL, Sunderland J, Acevedo M, Donovan M: Pharmacoimaging of blood-brain barrier permeable (FDG) and impermeable (FLT) substrates after intranasal (IN) administration. The AAPS journal 2018, 20(1):15.
  318. Portilho FL, Helal-Neto E, Cabezas SS, Pinto SR, dos Santos SN, Pozzo L, Sancenón F, Martínez-Máñez R, Santos-Oliveira R: Magnetic core mesoporous silica nanoparticles doped with dacarbazine and labelled with 99mTc for early and differential detection of metastatic melanoma by single photon emission computed tomography. Artificial cells, nanomedicine, and biotechnology 2018:1-8.
  319. Prando S, Carneiro CdG, Otsuki DA, Sapienza MT: Effects of ketamine/xylazine and isoflurane on rat brain glucose metabolism measured by 18F‐fluorodeoxyglucose‐positron emission tomography. European Journal of Neuroscience 2018.
  320. Prause M, Niedermoser S, Wängler C, Decristoforo C, Seibold U, Riester S, Taguchi T, Schirrmacher R, Fricker G, Wängler B: Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors. Nuclear medicine and biology 2018, 57:1-11.
  321. Puig O, Vestergaard MB, Lindberg U, Hansen AE, Ulrich A, Andersen FL, Johannesen HH, Rostrup E, Law I, Larsson HB: Phase contrast mapping MRI measurements of global cerebral blood flow across different perfusion states–A direct comparison with 15O-H2O positron emission tomography using a hybrid PET/MR system. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18798762.
  322. Putzu A, Valtorta S, Di Grigoli G, Haenggi M, Belloli S, Malgaroli A, Gemma M, Landoni G, Beretta L, Moresco RM: Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [18 F] FDG Positron Emission Tomography and Autoradiography. Neurocritical care 2018, 28(3):370-378.
  323. Pyo A, Kim H-S, Kim G, Kim H-S, Yun M, Kim D-Y, Min J-J: N-(2-(dimethylamino) ethyl)-4-18F-fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma. Journal of Nuclear Medicine 2018:jnumed. 118.221416.
  324. Raffel DM, Jung Y-W, Koeppe RA, Jang KS, Gu G, Scott PJ, Murthy VL, Rothley J, Frey KA: First-in-Human Studies of [18F] Fluorohydroxyphenethylguanidines: Positron Emission Tomography Radiotracers for Quantifying Regional Cardiac Sympathetic Nerve Density. Circulation: Cardiovascular Imaging 2018, 11(12):e007965.
  325. Reesink F, SNM DV, NM C, Peretti D, Willemsen A, Boellaard R, Meles S, Huitema R, de Jong B, Dierckx R: Crossed Cerebellar Diaschisis in Alzheimer’s Disease. Current Alzheimer Research 2018, 15(13):1267-1275.
  326. Reis ES, Berger N, Wang X, Koutsogiannaki S, Doot RK, Gumas JT, Foukas PG, Resuello RR, Tuplano JV, Kukis D: Safety profile after prolonged C3 inhibition. Clinical Immunology 2018, 197:96-106.
  327. Röhrich M, Huang K, Schrimpf D, Albert NL, Hielscher T, von Deimling A, Schüller U, Dimitrakopoulou-Strauss A, Haberkorn U: Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas. European journal of nuclear medicine and molecular imaging 2018:1-12.
  328. Rokugawa T, Konishi H, Ito M, Iimori H, Nagai R, Shimosegawa E, Hatazawa J, Abe K: Evaluation of hepatic integrin αvβ3 expression in non-alcoholic steatohepatitis (NASH) model mouse by 18 F-FPP-RGD 2 PET. EJNMMI research 2018, 8(1):40.
  329. Rosenkranz AA, Slastnikova TA, Karmakova TA, Vorontsova MS, Morozova NB, Petriev VM, Abrosimov AS, Khramtsov YV, Lupanova TN, Ulasov AV: Antitumor activity of Auger electron emitter 111In delivered by modular nanotransporter for treatment of bladder cancer with EGFR overexpression. Frontiers in pharmacology 2018, 9:1331.
  330. Rubin LH, Sacktor N, Creighton J, Du Y, Endres CJ, Pomper MG, Coughlin JM: Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy. AIDS (London, England) 2018, 32(12):1661.
  331. Saanijoki T, Tuominen L, Tuulari JJ, Nummenmaa L, Arponen E, Kalliokoski K, Hirvonen J: Opioid release after high-intensity interval training in healthy human subjects. Neuropsychopharmacology 2018, 43(2):246.
  332. Sabri O, Meyer PM, Gräf S, Hesse S, Wilke S, Becker G-A, Rullmann M, Patt M, Luthardt J, Wagenknecht G: Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer’s dementia. Brain 2018, 141(6):1840-1854.
  333. Sachpekidis C, Anwar H, Winkler JK, Kopp-Schneider A, Larribere L, Haberkorn U, Hassel JC, Dimitrakopoulou-Strauss A: Longitudinal studies of the 18 F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT. Cancer Immunology, Immunotherapy 2018:1-10.
  334. Sachpekidis C, Bäumer P, Kopka K, Hadaschik B, Hohenfellner M, Kopp-Schneider A, Haberkorn U, Dimitrakopoulou-Strauss A: 68 Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer. European journal of nuclear medicine and molecular imaging 2018:1-9.
  335. Sachpekidis C, Pan L, Hadaschik BA, Kopka K, Haberkorn U, Dimitrakopoulou-Strauss A: 68Ga-PSMA-11 PET/CT in prostate cancer local recurrence: impact of early images and parametric analysis. American journal of nuclear medicine and molecular imaging 2018, 8(5):351.
  336. Sang S, Pan X, Chen Z, Zeng F, Pan S, Liu H, Jin L, Fei G, Wang C, Ren S: Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not. Alzheimer’s research & therapy 2018, 10(1):26.
  337. Sauerbeck J, Ishii K, Hosokawa C, Kaida H, Scheiwein FT, Hanaoka K, Rominger A, Brendel M, Bartenstein P, Murakami T: The correlation between striatal and cortical binding ratio of 11 C-PiB-PET in amyloid-uptake-positive patients. Annals of nuclear medicine 2018:1-6.
  338. Schinke C, Hesse S, Rullmann M, Becker G-A, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K: Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Stress 2018:1-10.
  339. Schramm G, Koole M, Willekens S, Rezaei A, Van Weehaeghe D, Delso G, Peeters R, Mertens N, Nuyts J, Van Laere K: Regional accuracy of ZTE-based attenuation correction in static and dynamic brain PET/MR. arXiv preprint arXiv:180603481 2018.
  340. Schreiber-Stainthorp W, Sinharay S, Srinivasula S, Shah S, Wang J, Dodd L, Lane HC, Di Mascio M, Hammoud DA: Brain 18 F-FDG PET of SIV-infected macaques after treatment interruption or initiation. Journal of neuroinflammation 2018, 15(1):207.
  341. Sciagrà R, Milan E, Giubbini R, Kubik T, Di Dato R, Gallo L, Camoni L, Allocca M, Calabretta R: Sub-endocardial and sub-epicardial measurement of myocardial blood flow using 13 NH 3 PET in man. Journal of Nuclear Cardiology 2018:1-10.
  342. Seith F, Martirosian P, Nikolaou K, la Fougère C, Schwenzer N, Schmidt H: Computed diffusion weighted imaging (cDWI) and voxelwise-computed diffusion weighted imaging (vcDWI) for oncologic liver imaging: A pilot study. European Journal of Radiology Open 2018, 5:108-113.
  343. Seo Y, Pak K, Nam H-Y, Seok JW, Lee MJ, Kim E-J, Lee JM, Kim SJ, Kim IJ: Effect of rs3910105 in the Synuclein Gene on Dopamine Transporter Availability in Healthy Subjects. Yonsei medical journal 2018, 59(6):787-792.
  344. Serrano ME, Bahri MA, Becker G, Seret A, Mievis F, Giacomelli F, Lemaire C, Salmon E, Luxen A, Plenevaux A: Quantification of [18 F] UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value. Molecular Imaging and Biology 2018:1-10.
  345. Shao G, Wang Y, Liu X, Zhao M, Song J, Huang P, Wang F, Wang Z: Investigation of Newly Prepared Biodegradable 32P-chromic Phosphate-polylactide-co-glycolide Seeds and Their Therapeutic Response Evaluation for Glioma Brachytherapy. Contrast media & molecular imaging 2018, 2018.
  346. Shi X, Li N, Ding H, Dang Y, Hu G, Liu S, Cui J, Zhang Y, Li F, Zhang H: Comparison among Reconstruction Algorithms for Quantitative Analysis of 11C-Acetate Cardiac PET Imaging. Contrast media & molecular imaging 2018, 2018.
  347. Shinotoh H, Shimada H, Kokubo Y, Tagai K, Niwa F, Kitamura S, Endo H, Ono M, Kimura Y, Hirano S: Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula. Neurology 2018:10.1212/WNL. 0000000000006736.
  348. Shokri-Kojori E, Wang G-J, Wiers CE, Demiral SB, Guo M, Kim SW, Lindgren E, Ramirez V, Zehra A, Freeman C: β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proceedings of the National Academy of Sciences 2018, 115(17):4483-4488.
  349. Shrestha S, Singh P, Cortes-Salva MY, Jenko KJ, Ikawa M, Kim M-J, Kobayashi M, Morse CL, Gladding RL, Liow J-S: 3-Substituted 1, 5-Diaryl-1 H-1, 2, 4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 2: Selection and Evaluation of [11C] PS13 for Quantitative Imaging. ACS chemical neuroscience 2018.
  350. Silva RB, Greggio S, Venturin GT, da Costa JC, Gomez MV, Campos MM: Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis. Molecular neurobiology 2018:1-21.
  351. Silvester AJ, Aseer KR, Jang H-J, Ryu R, Kwon E-Y, Park JG, Cho K-H, Chaudhari HN, Choi M-S, Suh P-G: Loss of DJ-1 promotes browning of white adipose tissue in diet-induced obese mice. The Journal of nutritional biochemistry 2018, 61:56-67.
  352. Simón-Gracia L, Scodeller P, Fuentes SS, Vallejo VG, Ríos X, San Sebastián E, Sidorenko V, Di Silvio D, Suck M, De Lorenzi F: Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice. Oncotarget 2018, 9(27):18682.
  353. Singh N, Veronese M, O’Doherty J, Sementa T, Bongarzone S, Cash D, Simmons C, Arcolin M, Marsden PK, Gee A: Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging. Nuclear medicine and biology 2018, 66:32-39.
  354. Skriba A, Pluhacek T, Palyzova A, Novy Z, Lemr K, Hajduch M, Petrik M, Havlicek V: Early and non-invasive diagnosis of aspergillosis revealed by infection kinetics monitored in a rat model. Frontiers in Microbiology 2018, 9.
  355. Smit M, Vállez García D, De Jong BM, Zoons E, Booij J, Dierckx RA, Willemsen AT, de Vries EF, Bartels AL, Tijssen MA: Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C] DASB Positron Emission Tomography Study. Frontiers in neurology 2018, 9:88.
  356. Smith CT, Dang LC, Burgess LL, Perkins SF, San Juan MD, Smith DK, Cowan RL, Le NT, Kessler RM, Samanez-Larkin GR: Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18 F] fallypride PET. Psychopharmacology 2018:1-10.
  357. Smith CT, San Juan MD, Dang LC, Katz DT, Perkins SF, Burgess LL, Cowan RL, Manning HC, Nickels ML, Claassen DO: Ventral striatal dopamine transporter availability is associated with lower trait motor impulsivity in healthy adults. Translational psychiatry 2018, 8(1):269.
  358. Smith R, Schöll M, Londos E, Ohlsson T, Hansson O: 18 F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies. Scientific reports 2018, 8(1):4717.
  359. Smith R, Wibom M, Pawlik D, Englund E, Hansson O: Correlation of In Vivo [18F] Flortaucipir With Postmortem Alzheimer Disease Tau Pathology. JAMA neurology 2018.
  360. Son HJ, Jeong YJ, Yoon HJ, Lee SY, Choi G-E, Park J-A, Kim MH, Lee KC, Lee YJ, Kim MK: Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18 F-flutemetamol and 18 F-florbetaben. BMC neuroscience 2018, 19(1):45.
  361. Spies M, James GM, Vraka C, Philippe C, Hienert M, Gryglewski G, Komorowski A, Kautzky A, Silberbauer L, Pichler V: Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Translational psychiatry 2018, 8(1):198.
  362. Spinelli F, Haider A, Toscano A, Pati ML, Keller C, Berardi F, Colabufo NA, Abate C, Ametamey SM: Synthesis, radiolabelling, and evaluation of [11C] PB212 as a radioligand for imaging sigma-1 receptors using PET. American journal of nuclear medicine and molecular imaging 2018, 8(1):32.
  363. Stark AJ, Smith CT, Lin Y-C, Petersen KJ, Trujillo P, Van Wouwe NC, Kang H, Donahue MJ, Kessler RM, Zald DH: Nigrostriatal and mesolimbic D2/3 receptor expression in Parkinson’s disease patients with compulsive reward-driven behaviors. Journal of Neuroscience 2018:3082-3017.
  364. Stark AJ, Smith CT, Petersen KJ, Trujillo P, van Wouwe NC, Donahue MJ, Kessler RM, Deutch AY, Zald DH, Claassen DO: [18F] fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson’s disease. NeuroImage: Clinical 2018, 18:433-442.
  365. Steffen DA, Giannopoulos AA, Grossmann M, Messerli M, Schwyzer M, Gräni C, Gebhard C, Pazhenkottil AP, Kaufmann PA, Buechel RR: “Apical thinning”: Relations between myocardial wall thickness and apical left ventricular tracer uptake as assessed with positron emission tomography myocardial perfusion imaging. Journal of Nuclear Cardiology 2018:1-9.
  366. Stegmayr C, Stoffels G, Kops ER, Lohmann P, Galldiks N, Shah NJ, Neumaier B, Langen K-J: Influence of Dexamethasone on O-(2-[18 F]-Fluoroethyl)-l-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake. Molecular Imaging and Biology 2018:1-7.
  367. Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Parbo P, Borghammer P: Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder. Neurobiology of disease 2018, 115:9-16.
  368. Summer D, Mayr S, Petrik M, Rangger C, Schoeler K, Vieider L, Matuszczak B, Decristoforo C: Pretargeted Imaging with Gallium-68—Improving the Binding Capability by Increasing the Number of Tetrazine Motifs. Pharmaceuticals 2018, 11(4):102.
  369. Sun H, Zhang B, Jiang X, Liu H, Deng S, Li Z, Shi H: Radiolabeled ultra-small Fe3O4 nanoprobes for tumor-targeted multimodal imaging. Nanomedicine 2018, 13(24).
  370. Sundar LK, Muzik O, Rischka L, Hahn A, Rausch I, Lanzenberger R, Hienert M, Klebermass E-M, Füchsel F-G, Hacker M: Towards quantitative [18F] FDG-PET/MRI of the brain: Automated MR-driven calculation of an image-derived input function for the non-invasive determination of cerebral glucose metabolic rates. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18776820.
  371. Taddio MF, Mu L, Keller C, Schibli R, Krämer SD: Physiologically Based Pharmacokinetic Modelling with Dynamic PET Data to Study the In Vivo Effects of Transporter Inhibition on Hepatobiliary Clearance in Mice. Contrast Media & Molecular Imaging 2018, 2018.
  372. Takahashi K, Hosoya T, Onoe K, Takashima T, Tanaka M, Ishii A, Nakatomi Y, Tazawa S, Takahashi K, Doi H: Association between aromatase in human brains and personality traits. Scientific reports 2018, 8.
  373. Takano A, Chen L, Nag S, Brodney MA, Arakawa R, Chang C, Amini N, Doran SD, Dutra JK, McCarthy TJ: Quantitative Analysis of 18F-PF-06684511, a Novel PET Radioligand for Selective β-secretase 1 Imaging, in Non-human Primate Brain. Journal of Nuclear Medicine 2018:jnumed. 118.217372.
  374. Tang D, Fujinaga M, Hatori A, Zhang Y, Yamasaki T, Xie L, Mori W, Kumata K, Liu J, Manning HC: Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([18F] fluoroethoxy) phenyl)-5-methylpyrazolo [1, 5-a] pyrimidin-3-yl)-N, N-diethylacetamide in a preclinical model of neuroinflammation. European journal of medicinal chemistry 2018, 150:1-8.
  375. Tang D, Li J, Nickels ML, Huang G, Cohen AS, Manning HC: Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18 F] Fluoroethoxy) phenyl)-5-Methylpyrazolo [1, 5-a] Pyrimidin-3-yl)-N, N-Diethylacetamide (18 F-VUIIS1018A) to Image Glioma. Molecular Imaging and Biology 2018:1-9.
  376. Tateno A, Sakayori T, Kim W-c, Honjo K, Nakayama H, Arakawa R, Okubo Y: Comparison of dopamine D3 and D2 receptor occupancies by a single dose of blonanserin in healthy subjects: A positron emission tomography study with [11C]-(+)-PHNO. International Journal of Neuropsychopharmacology 2018, 21(6):522-527.
  377. ter Voert EE, Muehlematter UJ, Delso G, Pizzuto DA, Müller J, Nagel HW, Burger IA: Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical 68 Ga-PSMA PET/MR. EJNMMI research 2018, 8(1):70.
  378. Testa A, Dall’Angelo S, Mingarelli M, Augello A, Schweiger L, Welch A, Elmore CS, Dawson D, Sharma P, Zanda M: Preclinical Evaluation of [18F] LCATD as a PET tracer to study drug-drug interactions caused by inhibition of hepatic transporters. Contrast Media & Molecular Imaging 2018.
  379. Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, Thongpraparn T, Chanachai R, Gelovani J: Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer’s disease: first-hand experience in Thailand. Nuclear medicine communications 2018, 39(2):186-192.
  380. Thonglim P, Sungkarat W, Chotipanich C, Somphonsane R, Phoemphoonthanyakit S, Buranasiri P: The optimized time of 18 F-THK5351 PET/CT in normal thai population. In: Biophotonics: Photonic Solutions for Better Health Care VI: 2018: International Society for Optics and Photonics; 2018: 106852A.
  381. Toramatsu C, Yoshida E, Wakizaka H, Mohammadi A, Ikoma Y, Tashima H, Nishikido F, Kitagawa A, Karasawa K, Hirano Y: Washout effect in rabbit brain: in-beam PET measurements using 10C, 11C and 15O ion beams. Biomedical Physics & Engineering Express 2018, 4(3):035001.
  382. Tsai S-Y, Wang S-Y, Wu Y-W: Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction. Journal of Nuclear Medicine 2018, 59(supplement 1):226-226.
  383. Tsartsalis S, Tournier BB, Graf CE, Ginovart N, Ibáñez V, Millet P: Dynamic image denoising for voxel-wise quantification with Statistical Parametric Mapping in molecular neuroimaging. PloS one 2018, 13(9):e0203589.
  384. Tsartsalis S, Tournier BB, Habiby S, Hamadi MB, Barca C, Ginovart N, Millet P: Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D2/3 and 5-HT2A receptors. Neuroimage 2018, 176:528-540.
  385. Tseng J-R, Yang L-Y, Lin Y-C, Liu C-Y, Pang S-T, Hong J-H, Yen T-C, Wang L-J: Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer. Contrast media & molecular imaging 2018, 2018.
  386. Unterrainer M, Fleischmann D, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J: Comparison of 18 F-GE-180 and dynamic 18 F-FET PET in high grade glioma: a double-tracer pilot study. European journal of nuclear medicine and molecular imaging 2018:1-11.
  387. Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic V: TSPO PET with [18 F] GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis. European journal of nuclear medicine and molecular imaging 2018, 45(8):1423-1431.
  388. van Duin ED, Kasanova Z, Hernaus D, Ceccarini J, Heinzel A, Mottaghy F, Mohammadkhani-Shali S, Winz O, Frank M, Beck MC: Striatal dopamine release and impaired reinforcement learning in adults with 22q11. 2 deletion syndrome. European Neuropsychopharmacology 2018.
  389. Van Laeken N, Pauwelyn G, Dockx R, Descamps B, Brans B, Peremans K, Baeken C, Goethals I, Vanhove C, De Vos F: Regional alterations of cerebral [18 F] FDG metabolism in the chronic unpredictable mild stress-and the repeated corticosterone depression model in rats. Journal of Neural Transmission 2018, 125(9):1381-1393.
  390. van Lierop ZY, Jentjens S, Anten MH, Wierts R, Stumpel CT, Havekes B, van Kroonenburgh MJ: Thyroid Gland 18F-FDG Uptake in Neurofibromatosis Type 1. European Thyroid Journal 2018, 7(3):155-161.
  391. Verger A, Filss CP, Lohmann P, Stoffels G, Sabel M, Wittsack H-J, Kops ER, Galldiks N, Fink GR, Shah NJ: Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography and Perfusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Patients with Progressive and Recurrent Glioma: A Hybrid Positron Emission Tomography/Magnetic Resonance Study. World Neurosurgery 2018, 113:e727-e737.
  392. Verger A, Stoffels G, Galldiks N, Lohmann P, Willuweit A, Neumaier B, Geisler S, Langen K-J: Investigation of cis-4-[18 F] Fluoro-D-Proline Uptake in Human Brain Tumors After Multimodal Treatment. Molecular Imaging and Biology 2018:1-9.
  393. Verhaeghe J, Bertoglio D, Kosten L, Thomae D, Verhoye M, Van Der Linden A, Wyffels L, Stroobants S, Wityak J, Dominguez C: Noninvasive relative quantification of [11C] ABP688 PET imaging in mice versus an input function measured over an arteriovenous shunt. Frontiers in Neurology 2018, 9:516.
  394. Vettermann FJ, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Meyer PM, McLeod A, Brendel M, Blüher M: Noradrenaline transporter availability on [11 C] MRB PET predicts weight loss success in highly obese adults. European journal of nuclear medicine and molecular imaging 2018:1-8.
  395. Vidal B, Fieux S, Colom M, Billard T, Bouillot C, Barret O, Constantinescu C, Tamagnan G, Newman-Tancredi A, Zimmer L: 18 F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT 1A receptor agonist for PET neuroimaging. Brain Structure and Function 2018:1-16.
  396. Vignal N, Cisternino S, Rizzo-Padoin N, San C: Fortune Hontonnou 4, Thibaut Gelé, Xavier Declèves 2, 5, Laure Sarda-Mantel and Benoît Hosten. Current Aspects of Radiopharmaceutical Chemistry 2018, 23:114.
  397. Vignal N, Cisternino S, Rizzo-Padoin N, San C, Hontonnou F, Gelé T, Declèves X, Sarda-Mantel L, Hosten B: [18F] FEPPA a TSPO Radioligand: Optimized Radiosynthesis and Evaluation as a PET Radiotracer for Brain Inflammation in a Peripheral LPS-Injected Mouse Model. Molecules 2018, 23(6).
  398. Vomacka L, Unterrainer M, Holzgreve A, Mille E, Gosewisch A, Brosch J, Ziegler S, Suchorska B, Kreth F-W, Tonn J-C: Voxel-wise analysis of dynamic 18 F-FET PET: a novel approach for non-invasive glioma characterisation. EJNMMI research 2018, 8(1):91.
  399. Von Spiczak J, Manka R, Gotschy A, Oebel S, Kozerke S, Hamada S, Alkadhi H: Fusion of CT coronary angiography and whole-heart dynamic 3D cardiac MR perfusion: building a framework for comprehensive cardiac imaging. The international journal of cardiovascular imaging 2018, 34(4):649-660.
  400. von Spiczak J, Mannil M, Kozerke S, Alkadhi H, Manka R: 3D image fusion of whole‐heart dynamic cardiac MR perfusion and late gadolinium enhancement: Intuitive delineation of myocardial hypoperfusion and scar. Journal of Magnetic Resonance Imaging 2018.
  401. Vorobyeva A, Westerlund K, Mitran B, Altai M, Rinne S, Sörensen J, Orlova A, Tolmachev V, Karlström AE: Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy. Scientific reports 2018, 8(1):9643.
  402. Wan H, Tan Z, Zheng Q, Yu J: Metabolic Brain Network Analysis of Hypothyroidism Symptom Based on [18 F] FDG-PET of Rats. Molecular Imaging and Biology 2018:1-9.
  403. Wang L, Liu Y, Xu Y, Sheng J, Pan D, Wang X, Yan J, Yang R, Yang M: Age-related change of GLP-1R expression in rats can be detected by [18F] AlF-NOTA-MAL-Cys39-exendin-4. Brain research 2018, 1698:213-219.
  404. Wang W, Song N, Jia F, Tang T, Bao W, Zuo C, Xie J, Jiang H: Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson’s disease mouse model. Neurochemistry international 2018, 114:71-79.
  405. Wang Y, Shi Z, Zhang N, Cai L, Li Y, Yang H, Yao S, Xing X, Ji Y, Gao S: Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer’s Disease Corresponding to Brain Networks: a Prospective Cohort Study. Molecular Imaging and Biology 2018:1-9.
  406. Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR: Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nature medicine 2018:1.
  407. Warnock G, Özbay PS, Kuhn FP, Nanz D, Buck A, Boss A, Rossi C: Reduction of BOLD interference in pseudo-continuous arterial spin labeling: towards quantitative fMRI. Journal of Cerebral Blood Flow & Metabolism 2018, 38(5):847-856.
  408. Warnock G, Sommerauer M, Mu L, Gonzalez GP, Geistlich S, Treyer V, Schibli R, Buck A, Krämer SD, Ametamey SM: A first-in-man PET study of [18 F] PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5. European journal of nuclear medicine and molecular imaging 2018, 45(6):1041-1051.
  409. Wedekind F, Oskamp A, Lang M, Hawlitschka A, Zilles K, Wree A, Bauer A: Intrastriatal administration of botulinum neurotoxin A normalizes striatal D2R binding and reduces striatal D1R binding in male hemiparkinsonian rats. Journal of neuroscience research 2018, 96(1):75-86.
  410. Weigend S, Holst SC, Treyer V, Tuura RLG, Meier J, Ametamey SM, Buck A, Landolt H-P: Dynamic changes in cerebral and peripheral markers of glutamatergic signaling across the human sleep-wake cycle. bioRxiv 2018:458885.
  411. Weir G, Ramage LE, Akyol M, Rhodes JK, Kyle CJ, Fletcher AM, Craven TH, Wakelin SJ, Drake AJ, Gregoriades M-L: Substantial Metabolic Activity of Human Brown Adipose Tissue during Warm Conditions and Cold-Induced Lipolysis of Local Triglycerides. Cell metabolism 2018.
  412. Weng Y-C, Hsiao I-T, Huang C-Y, Huang K-L, Liu C-H, Chang T-Y, Yen T-C, Lin K-J, Huang C-C: Progress of Brain Amyloid Deposition in Familial Alzheimer’s Disease with Taiwan D678H APP Mutation. Journal of Alzheimer’s Disease 2018(Preprint):1-13.
  413. Wilson T, Xavier M-A, Knight J, Verhoog S, Torres JB, Mosley M, Hopkins S, Wallington S, Allen D, Kersemans V: PET imaging of PARP expression using [18F] olaparib. Journal of Nuclear Medicine 2018:jnumed. 118.213223.
  414. Wimberley C, Lavisse S, Brulon V, Peyronneau M-A, Leroy C, Bodini B, Remy P, Stankoff B, Buvat I, Bottlaender M: Impact of endothelial 18-kDa translocator protein on the quantification of 18F-DPA-714. J Nucl Med 2018, 59:307-314.
  415. Wirth M, Bejanin A, La Joie R, Arenaza-Urquijo EM, Gonneaud J, Landeau B, Perrotin A, Mézenge F, de La Sayette V, Desgranges B: Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer’s disease. Neurobiology of aging 2018, 63:140-151.
  416. Wu KY, Lin KJ, Chen CH, Chen CS, Liu CY, Huang SY, Yen TC, Hsiao IT: Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: Evidence of cerebral amyloidosis and hippocampal atrophy. Brain and behavior 2018:e01016.
  417. Wu K-Y, Hsiao T, Chen C-H, Liu C-Y, Hsu J-L, Huang S-Y, Yen T-C, Lin K-J: Plasma Aβ analysis using magnetically-labeled immunoassays and PET 18 F-florbetapir binding in non-demented patients with major depressive disorder. Scientific reports 2018, 8(1):2739.
  418. Xu L, Tetteh G, Lipkova J, Zhao Y, Li H, Christ P, Piraud M, Buck A, Shi K, Menze BH: Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on 68Ga-Pentixafor PET/CT Imaging Using Deep Learning Methods. Contrast media & molecular imaging 2018, 2018.
  419. Yajima S, Miyagawa S, Fukushima S, Sakai Y, Isohashi K, Watabe T, Ikeda H, Horitsugi G, Harada A, Sakaniwa R: A prostacyclin agonist and an omental flap increased myocardial blood flow in a porcine chronic ischemia model. The Journal of thoracic and cardiovascular surgery 2018.
  420. Yalcin H, Valenta I, Zhao M, Tahari A, Lu D-Y, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy. Journal of Nuclear Cardiology 2018:1-11.
  421. Yamasaki T, Mori W, Zhang Y, Hatori A, Fujinaga M, Wakizaka H, Kurihara Y, Wang L, Nengaki N, Ohya T: First demonstration of in vivo mapping for regional brain monoacylglycerol lipase using PET with [11C] SAR127303. NeuroImage 2018, 176:313-320.
  422. Yang K-C, Takano A, Halldin C, Farde L, Finnema SJ: Serotonin concentration enhancers at clinically relevant doses reduce [11 C] AZ10419369 binding to the 5-HT 1B receptors in the nonhuman primate brain. Translational psychiatry 2018, 8(1):132.
  423. Yi H-A, Won KS, Chang HW, Kim HW: Association between white matter lesions and cerebral Aβ burden. PloS one 2018, 13(9):e0204313.
  424. Yokoi T, Watanabe H, Yamaguchi H, Bagarinao E, Masuda M, Imai K, Ogura A, Ohdake R, Kawabata K, Hara K: Involvement of the precuneus/posterior cingulate cortex is significant for the development of Alzheimer’s disease: A PET (THK5351, PiB) and resting fMRI study. Frontiers in aging neuroscience 2018, 10:304.
  425. Yokokawa K, Ito T, Takahata K, Takano H, Kimura Y, Ichise M, Ikoma Y, Isato A, Zhang M-R, Kawamura K: Neuromolecular basis of faded perception associated with unreality experience. Scientific reports 2018, 8(1):8062.
  426. Yoo J, Kim BS, Yoon H-J: Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer. Annals of nuclear medicine 2018, 32(5):328-336.
  427. Yoon CW, Jeong HJ, Seo S, Lee S-Y, Suh MK, Heo J-H, Lee Y-B, Park KH, Okamura N, Lee K-M: 18F-THK5351 PET Imaging in Nonfluent-Agrammatic Variant Primary Progressive Aphasia. Dementia and Neurocognitive Disorders 2018, 17(3):110-119.
  428. Yousaf T, Pagano G, Niccolini F, Politis M: Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness. Sleep medicine 2018, 43:25-30.
  429. Zanirati G, Azevedo PN, Venturin GT, Greggio S, Alcará AM, Zimmer ER, Feltes PK, DaCosta JC: Depression comorbidity in epileptic rats is related to brain glucose hypometabolism and hypersynchronicity in the metabolic network architecture. Epilepsia 2018, 59(5):923-934.
  430. Zanotti-Fregonara P, Pascual B, Rizzo G, Yu M, Pal N, Beers D, Carter R, Appel SH, Atassi N, Masdeu JC: Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain. Journal of Nuclear Medicine 2018, 59(8):1260-1266.
  431. Zeissig S, Rosati E, Dowds CM, Aden K, Bethge J, Schulte B, Pan WH, Mishra N, Zuhayra M, Marx M: Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease. Gut 2018:gutjnl-2018-316023.
  432. Zeng Y, Hu D, Yang W, Hayashinaka E, Wada Y, Watanabe Y, Zeng Q, Cui Y: A voxel-based analysis of neurobiological mechanisms in placebo analgesia in rats. NeuroImage 2018.
  433. Zhou W, Bao W, Jiang D, Kong Y, Hua F, Lu X, Guan Y: [18F]-GE-179 positron emission tomography (PET) tracer for N-methyl-d-aspartate receptors: One-pot synthesis and preliminary micro-PET study in a rat model of MCAO. Nuclear medicine and biology 2018, 61:45-55.
  434. Zhu Z, Chung Y-M, Sergeeva O, Kepe V, Berk M, Li J, Ko H-K, Li Z, Petro M, DiFilippo FP: Loss of dihydrotestosterone-inactivation activity promotes prostate cancer castration resistance detectable by functional imaging. Journal of Biological Chemistry 2018, 293(46):17829-17837.
  435. Zoppolo F: Biological and dosimetric evaluation of [11 C] S-adenosyl Methionine as a potential agent for prostate cancer diagnosis. Cancer Research Frontiers 2018, 4(1):27-44.
  436. Zoufal V, Wanek T, Krohn M, Mairinger S, Filip T, Sauberer M, Stanek J, Pekar T, Bauer M, Pahnke J: Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18806640.
  437. Zwirner K, Thorwarth D, Winter RM, Welz S, Weiss J, Schwenzer NF, Schmidt H, la Fougère C, Nikolaou K, Zips D: Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup. Strahlentherapie und Onkologie 2018:1-8.